The Role Of Fine Needle Aspiration Cytology In Diagnosis Of Focal Liver Lesions In Khartoum State by Abd Elmohsin, Khalid
ﻢﺴﺑ ﷲا ﻦﻤﺣﺮﻟا ﻢﻴﺣﺮﻟا  
University of Khartoum 
Graduate College  
Medical & Health Studies Board  
 
 
THE ROLE OF FINE NEEDLE ASPIRATION CYTOLOGY IN 
DIAGNOSIS OF FOCAL LIVER LESIONS IN  
KHARTOUM STATE 
 
 
  
By 
Khalid Abd Elmohsin Awad Elseed Idris 
MBBS Omdurman Islamic University, 1998 
 
A thesis submitted in partial fulfillment for the requirements of the degree of Clinical 
MD in Pathology, 2010 
 
 
 
 
Supervisor  
Dr: Mohammed Osman Mohammed  
MBBS, MD, Pathologist  
Assistant Professor 
 of Clinical Pathology 
U of K  
 
  
  
 
Chapter one 
Introduction  
Literature review and objectives 
 
 Dedication  
To my parents for their life long support, love, and 
encouragement. 
To my wife, daughter, son, sisters, and brothers, whose 
support made every thing possible. 
To my teacher, late Dr: Eltaib Elaasha (1943 – 2002) 
Without his support I would not joined the Discipline of 
pathology .He left a legacy of excellence that will enrich the 
life of generation of future doctors. 
To my faithful teacher Dr: Mohammed Abdel Hameed whose 
support is the foundation on which pursues my academic 
aspiration. 
To all who strive for improving the health of every one. 
 
 Acknowledgement 
At the beginning, and at the end all thank, Allah, for helping 
me in doing and completing this work. 
I am very grateful to my supervisor Dr. Mohamed Mohamed 
Osman, who helped me with his time and his patience. His 
encouragement and trust help me too much to complete my 
work. 
Special thanks to Dr. Ahmed Omer Almobarak without his 
help this work would not be possible, hoping that God will 
bless him with his love that makes every thing a joy to life.  
Best regards to my family for their help, support, and 
encouragement during the period of the research to overcome 
all the difficulties which faced me. 
I'm very grateful to Dr. Mohammed Altaib for his support 
and advice  
It is with great pleasure to acknowledge the help of Dr: 
Muneer A.Y. Abbas for typing.  
My thanks to all people who helped me, and I may have 
missed to mention their names. 
Khalid 
 ABSTRACT 
 
Introduction: Focal liver lesions constitute a major stress to the patient, 
and challenge for the pathologist in term of diagnosis by fine needle aspiration 
cytology.  
Aim: To evaluate the role of imaging guided fine needle aspiration 
cytology (FNAC) in diagnosis of focal liver lesions. 
Methods: In a retrospective study between 2007 – 2009 in venue of 
Police Hospital and Khartoum Clinic, on 61 Sudanese patients with unifocal or 
multifocal liver lesion, diagnosed radiologically. Fine needle aspiration of a 
liver lesion was done guided by ultrasound in the 57 cases and by computed 
tomographic scan in 4 cases.     
Results: Thirty-two (52.5%) patients from Khartoum State and 
29(47.5%) patients from outside Khartoum. Patients’age range from 1-82 years, 
with preponderance of male (75.4%). Morphologically, malignant lesions 
constituted 72% and benign lesions 28% for both uni and multifocal liver 
lesions. For unifocal lesions malignancy was found in 60% and benign lesions 
in 37% and 3% of cases were suspicious. For multifocal liver lesions 85% were 
malignant and 15% were benign. Secondary malignancies were more common 
than primary malignancy, constituting 71% and 77% for unifocal, multifocal 
liver lesions respectively.    
Primary malignant liver tumours were 29% of uni focal and 18% of 
multifocal lesions. In one patient there was a need for liver biopsy and 
immunostain to arrive at a final diagnosis of malignancy.   
Conclusion: it is concluded that FNAC is useful technique in evaluating 
focal liver lesions. It is simple, safe, and what made it more useful is the better 
coordination between radiologist, pathologist, and clinicians. 
  
 
  ﺺ ـــﻤﺴﺘﺨﻠاﻟ
  
ﺘﺸﻜل ﺍﻵﻓﺎﺕ ﺍﻟﺒﺅﺭﻴﺔ ﻟﻠﻜﺒﺩ ﻤﺼﺩﺭ ﻗﻠﻕ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻠﻤﺭﻴﺽ ﻭﺘﺤﺩﻱ   :ﺍﻟﻤﻘﺩﻤﺔ
  .ﻹﺨﺘﺼﺎﺼﻲ ﻋﻠﻡ ﺍﻷﻤﺭﺍﺽ ﻤﻥ ﺤﻴﺙ ﺘﺸﺨﻴﺼﻬﺎ ﺒﺎﻟﺭﺸﻑ ﺒﺎﻹﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ
ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﺘﺤﺩﻴﺩ ﻭﺘﻘﻴﻴﻡ  ﺩﻭﺭ ﺍﻟﺭﺸﻑ ﺒﺎﻹﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ ﻓﻲ  :ﺍﻷﻫﺩﺍﻑ
  . ﺘﺸﺨﻴﺹ ﺃﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﺒﺅﺭﻴﺔ
ﻡ، ﺒﻤﺴﺘﺸﻔﻰ 9002 –ﻡ 7002ﻓﻲ ﺩﺭﺍﺴﺔ ﺇﺭﺘﺠﺎﻋﻴﺔ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ  :ﻤﻨﻬﺠﻴﺔ ﺍﻟﺒﺤﺙ
ﻤﺭﻴﺽ ﺴﻭﺩﺍﻨﻲ ﻟﺩﻴﻬﻡ ﺃﻓﺎﺕ ﺒﺅﺭﻴﺔ ﺒﺎﻟﻜﺒﺩ ﻭﺤﻴﺩﺓ ﺃﻭ  16ﺍﻟﺸﺭﻁﺔ ﻭﻋﻴﺎﺩﺓ ﺍﻟﺨﺭﻁﻭﻡ ﻋﻠﻰ 
ﺒﺎﻟﻤﻭﺠﺎﺕ ﻓﻭﻕ  ﺔ، ﻭﻤﻥ ﺜﻡ ﺘﻡ ﺍﻟﺭﺸﻑ ﺒﺎﻷﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ ﺍﻟﻤﻭﺠﻬﻤﺘﻌﺩﺩﺓ، ﺘﻡ ﺘﺸﺨﻴﺼﻬﺎ ﺸﻌﺎﻋﻴﺎﹰ
  . ﺤﺎﻻﺕ ﻤﻭﺠﻬﺔ ﺒﺎﻷﺸﻌﺔ ﺍﻟﻤﻘﻁﻌﻴﺔ 4ﺤﺎﻟﺔ ﻭ ﻓﻲ  75ﺍﻟﺼﻭﺘﻴﺔ ﻓﻲ 
%( 5.74)92ﻤﻥ ﺩﺍﺨل ﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡ ﻭ %( 5.25) 23ﻋﺩﺩ ﺍﻟﻤﺭﻀﻰ  :ﺍﻟﻨﺘﺎﺌﺞ
ﺴﻨﺔ، ﻤﻊ ﺍﺭﺘﻔﺎﻉ ﻨﺴﺒﺔ ﺍﻟﺫﻜﻭﺭ  28ﺇﻟﻰ  1ﺘﺭﺍﻭﺤﺕ ﺃﻋﻤﺎﺭ ﺍﻟﻤﺭﻀﻰ ﻤﻥ . ﺨﺎﺭﺠﻬﺎ
، % 27ﻭﺠﺩ ﺃﻥ ﺍﻵﻓﺎﺕ ﺍﻟﺨﺒﻴﺜﺔ    ygolohproMﻨﺎﺤﻴﺔ ﺍﻟﺸﻜل ﺍﻟﻅﺎﻫﺭﻱ ﻤﻥ %(. 4.57)
ﺒﺎﻟﻨﺴﺒﺔ ﻵﻓﺎﺕ ﺍﻟﻜﺒﺩ . ﻟﻜل ﻤﻥ ﺁﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﺒﺅﺭﻴﺔ ﺍﻟﻭﺤﻴﺩﺓ ﻭﺍﻟﻤﺘﻌﺩﺩﺓ% 82ﻭﺍﻵﻓﺎﺕ ﺍﻟﺤﻤﻴﺩﺓ 
ﻟﻠﻤﺘﻌﺩﺩﺓ ﻜﺎﻨﺕ ﺍﻷﻭﺭﺍﻡ . ﺒﻬﺎ ﺸﻙ% 3ﺤﻤﻴﺩﺓ، % 73ﻤﻨﻬﺎ ﺃﻭﺭﺍﻡ ﺨﺒﻴﺜﺔ، ﻭ% 06ﺍﻟﻭﺤﻴﺩﺓ 
ﺨﺒﻴﺜﺔ ﺍﻟﺜﺎﻨﻭﻴﺔ ﻜﺎﻨﺕ ﺃﻜﺜﺭ ﺸﻴﻭﻋﺎﹰ ﻤﻥ ﺍﻷﻭﻟﻴﺔ ﺍﻷﻭﺭﺍﻡ ﺍﻟ. ﺤﻤﻴﺩﺓ% 51ﻭ % 58ﺍﻟﺨﺒﻴﺜﺔ 
ﺍﻷﻭﺭﺍﻡ . ﻵﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﺒﺅﺭﻴﺔ ﺍﻟﻭﺤﻴﺩﺓ ﻭﺍﻟﻤﺘﻌﺩﺩﺓ ﻋﻠﻰ ﺍﻟﺘﺭﺘﻴﺏ% 77ﻭ % 17ﺒﻨﺴﺒﺔ 
ﻭﺠﺩ ﻓﻲ ﻤﺭﻴﺽ . ﻟﻠﻭﺤﻴﺩﺓ ﻭﺍﻟﻤﺘﻌﺩﺩﺓ ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻲ% 81ﻭ % 92ﺍﻟﺨﺒﻴﺜﺔ ﺍﻷﻭﻟﻴﺔ ﺸﻜﻠﺕ 
  .ﻉ ﺍﻟﺨﺒﺎﺜﺔﻭﺍﺤﺩ ﺃﻥ ﻫﻨﺎﻙ ﺤﻭﺠﺔ ﻟﺨﺫﻋﺔ ﺍﻟﻜﺒﺩ ﻭﺍﺴﺘﻌﻤﺎل ﺍﻟﺼﺒﻐﺔ ﺍﻟﻤﻨﺎﻋﻴﺔ ﻟﺘﺤﺩﻴﺩ ﻨﻭ
ﺍﻟﺭﺸﻑ ﺒﺎﻹﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ ﺍﻟﻤﻭﺠﻪ ﺒﺎﻟﺼﻭﺭ ﺍﻹﺸﻌﺎﻋﻴﺔ ﻁﺭﻴﻘﺔ ﻤﻔﻴﺩﺓ ﻟﺘﻘﻴﻴﻡ  :ﺍﻟﺘﻀﻤﻴﻥ
ﺁﻓﺎﺕ ﺍﻟﻜﺒﺩ ﻭﻋﻠﻠﻪ ﻭﻫﻲ ﻋﻤﻠﻴﺔ ﺒﺴﻴﻁﺔ ﻭﺴﻬﻠﺔ ﻭﺍﻟﺘﺸﺨﻴﺹ ﺍﻟﺨﻠﻭﻱ ﺴﻬل ﻭﻤﻔﻴﺩ ﻓﻲ ﺘﺤﺩﻴﺩ 
ﻫﺫﻩ ﺍﻟﻌﻤﻠﻴﺔ ﻨﺎﺠﺤﺔ ﻓﻲ ﻭﺠﻭﺩ ﺨﺒﺭﺓ ﺒﺎﻟﺭﺸﻑ ﺍﻟﺩﻗﻴﻕ ﻭﺍﻟﺘﻨﺴﻴﻕ  ﺒﻴﻥ ﺇﺨﺘﺼﺎﺼﻲ . ﺍﻵﻓﺎﺕ
  .ﺍﻟﺴﺭﻴﺭﻱ ﺍﻷﺸﻌﺔ ﻭﺍﻷﻤﺭﺍﺽ ﻭﺍﻟﻤﺨﺘﺹ
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ABSTRACT 
Introduction: Focal liver lesions constitute a major stress to the patient, and 
challenge for the pathologist in term of diagnosis by fine needle aspiration 
cytology.  
Aim: To evaluate the role of imaging guided fine needle aspiration 
cytology (FNAC) in diagnosis of focal liver lesions. 
Methods: In a retrospective study between 2007 – 2009 in venue of Police 
Hospital and Khartoum Clinic, on 61 Sudanese patients with unifocal or 
multifocal liver lesion, diagnosed radiologically. Fine needle aspiration of a liver 
lesion was done guided by ultrasound in the 57 cases and by computed 
tomographic scan in 4 cases.     
Results: Thirty-two (52.5%) patients from Khartoum State and 29(47.5%) 
patients from outside Khartoum. Patients’age range from 1-82 years, with 
preponderance of male (75.4%). Morphologically, malignant lesions constituted 
72% and benign lesions 28% for both uni and multifocal liver lesions. For unifocal 
lesions malignancy was found in 60% and benign lesions in 37% and 3% of cases 
were suspicious. For multifocal liver lesions 85% were malignant and 15% were 
benign. Secondary malignancies were more common than primary malignancy, 
constituting 71% and 77% for unifocal, multifocal liver lesions respectively.    
Primary malignant liver tumours were 29% of uni focal and 18% of 
multifocal lesions. In one patient there was a need for liver biopsy and 
immunostain to arrive at a final diagnosis of malignancy.   
Conclusion: it is concluded that FNAC is useful technique in evaluating 
focal liver lesions. It is simple, safe, and what made it more useful is the better 
coordination between radiologist, pathologist, and clinicians. 
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  ﺺ ـــﻤﺴﺘﺨﻠاﻟ
ﺘﺸﻜل ﺍﻵﻓﺎﺕ ﺍﻟﺒﺅﺭﻴﺔ ﻟﻠﻜﺒﺩ ﻤﺼﺩﺭ ﻗﻠﻕ ﺒﺎﻟﻨﺴﺒﺔ ﻟﻠﻤﺭﻴﺽ ﻭﺘﺤﺩﻱ ﻹﺨﺘﺼﺎﺼﻲ   :ﺍﻟﻤﻘﺩﻤﺔ
  .ﻋﻠﻡ ﺍﻷﻤﺭﺍﺽ ﻤﻥ ﺤﻴﺙ ﺘﺸﺨﻴﺼﻬﺎ ﺒﺎﻟﺭﺸﻑ ﺒﺎﻹﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ
ﺍﻟﺭﺸﻑ ﺒﺎﻹﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ ﻓﻲ ﺘﺸﺨﻴﺹ ﺃﻓﺎﺕ ﻭﺘﻘﻴﻴﻡ  ﺩﻭﺭ ﺘﺤﺩﻴﺩ ﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻴﺃﺠﺭ :ﺍﻷﻫﺩﺍﻑ
  . ﺍﻟﻜﺒﺩ ﺍﻟﺒﺅﺭﻴﺔ
ﻡ، ﺒﻤﺴﺘﺸﻔﻰ ﺍﻟﺸﺭﻁﺔ 9002 –ﻡ 7002ﺔ ﺇﺭﺘﺠﺎﻋﻴﺔ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﻓﻲ ﺩﺭﺍﺴ :ﻤﻨﻬﺠﻴﺔ ﺍﻟﺒﺤﺙ
ﻴﺩﺓ ﺃﻭ ﻤﺘﻌﺩﺩﺓ، ﺘﻡ ﺤﺴﻭﺩﺍﻨﻲ ﻟﺩﻴﻬﻡ ﺃﻓﺎﺕ ﺒﺅﺭﻴﺔ ﺒﺎﻟﻜﺒﺩ ﻭ ﻤﺭﻴﺽ 16ﻭﻋﻴﺎﺩﺓ ﺍﻟﺨﺭﻁﻭﻡ ﻋﻠﻰ 
 75ﺒﺎﻟﻤﻭﺠﺎﺕ ﻓﻭﻕ ﺍﻟﺼﻭﺘﻴﺔ ﻓﻲ  ﺔﺘﺸﺨﻴﺼﻬﺎ ﺸﻌﺎﻋﻴﺎﹰ، ﻭﻤﻥ ﺜﻡ ﺘﻡ ﺍﻟﺭﺸﻑ ﺒﺎﻷﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ ﺍﻟﻤﻭﺠﻬ
   .ﺒﺎﻷﺸﻌﺔ ﺍﻟﻤﻘﻁﻌﻴﺔ ﺔﺤﺎﻻﺕ ﻤﻭﺠﻬ 4ﺤﺎﻟﺔ ﻭ ﻓﻲ 
 .ﺨﺎﺭﺠﻬﺎ%( 5.74)92ﻤﻥ ﺩﺍﺨل ﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡ ﻭ %( 5.25) 23ﻋﺩﺩ ﺍﻟﻤﺭﻀﻰ  :ﺍﻟﻨﺘﺎﺌﺞ
ﻤﻥ ﻨﺎﺤﻴﺔ %(. 4.57)ﺴﻨﺔ، ﻤﻊ ﺍﺭﺘﻔﺎﻉ ﻨﺴﺒﺔ ﺍﻟﺫﻜﻭﺭ  28ﺇﻟﻰ  1ﺘﺭﺍﻭﺤﺕ ﺃﻋﻤﺎﺭ ﺍﻟﻤﺭﻀﻰ ﻤﻥ 
ﻟﻜل % 82، ﻭﺍﻵﻓﺎﺕ ﺍﻟﺤﻤﻴﺩﺓ % 27ﻭﺠﺩ ﺃﻥ ﺍﻵﻓﺎﺕ ﺍﻟﺨﺒﻴﺜﺔ    ygolohproMﺍﻟﺸﻜل ﺍﻟﻅﺎﻫﺭﻱ 
ﻤﻨﻬﺎ ﺃﻭﺭﺍﻡ ﺨﺒﻴﺜﺔ، % 06ﺒﺎﻟﻨﺴﺒﺔ ﻵﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﻭﺤﻴﺩﺓ . ﻤﻥ ﺁﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﺒﺅﺭﻴﺔ ﺍﻟﻭﺤﻴﺩﺓ ﻭﺍﻟﻤﺘﻌﺩﺩﺓ
ﺍﻷﻭﺭﺍﻡ . ﺤﻤﻴﺩﺓ% 51ﻭ % 58ﻟﻠﻤﺘﻌﺩﺩﺓ ﻜﺎﻨﺕ ﺍﻷﻭﺭﺍﻡ ﺍﻟﺨﺒﻴﺜﺔ  .ﺒﻬﺎ ﺸﻙ% 3ﺤﻤﻴﺩﺓ، % 73ﻭ
ﻵﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﺒﺅﺭﻴﺔ ﺍﻟﻭﺤﻴﺩﺓ % 77ﻭ % 17ﺍﻟﺨﺒﻴﺜﺔ ﺍﻟﺜﺎﻨﻭﻴﺔ ﻜﺎﻨﺕ ﺃﻜﺜﺭ ﺸﻴﻭﻋﺎﹰ ﻤﻥ ﺍﻷﻭﻟﻴﺔ ﺒﻨﺴﺒﺔ 
ﻟﻠﻭﺤﻴﺩﺓ ﻭﺍﻟﻤﺘﻌﺩﺩﺓ ﻋﻠﻰ % 81ﻭ % 92ﺍﻷﻭﺭﺍﻡ ﺍﻟﺨﺒﻴﺜﺔ ﺍﻷﻭﻟﻴﺔ ﺸﻜﻠﺕ  .ﻭﺍﻟﻤﺘﻌﺩﺩﺓ ﻋﻠﻰ ﺍﻟﺘﺭﺘﻴﺏ
ﻭﺠﺩ ﻓﻲ ﻤﺭﻴﺽ ﻭﺍﺤﺩ ﺃﻥ ﻫﻨﺎﻙ ﺤﻭﺠﺔ ﻟﺨﺫﻋﺔ ﺍﻟﻜﺒﺩ ﻭﺍﺴﺘﻌﻤﺎل ﺍﻟﺼﺒﻐﺔ ﺍﻟﻤﻨﺎﻋﻴﺔ ﻟﺘﺤﺩﻴﺩ . ﺍﻟﺘﻭﺍﻟﻲ
  .ﻨﻭﻉ ﺍﻟﺨﺒﺎﺜﺔ
ﻌﺎﻋﻴﺔ ﻁﺭﻴﻘﺔ ﻤﻔﻴﺩﺓ ﻟﺘﻘﻴﻴﻡ ﺁﻓﺎﺕ ﺍﻟﻜﺒﺩ ﺍﻟﺭﺸﻑ ﺒﺎﻹﺒﺭ ﺍﻟﺩﻗﻴﻘﺔ ﺍﻟﻤﻭﺠﻪ ﺒﺎﻟﺼﻭﺭ ﺍﻹﺸ :ﺍﻟﺘﻀﻤﻴﻥ
ﻫﺫﻩ ﺍﻟﻌﻤﻠﻴﺔ . ﻭﻋﻠﻠﻪ ﻭﻫﻲ ﻋﻤﻠﻴﺔ ﺒﺴﻴﻁﺔ ﻭﺴﻬﻠﺔ ﻭﺍﻟﺘﺸﺨﻴﺹ ﺍﻟﺨﻠﻭﻱ ﺴﻬل ﻭﻤﻔﻴﺩ ﻓﻲ ﺘﺤﺩﻴﺩ ﺍﻵﻓﺎﺕ
ﺍﻷﺸﻌﺔ ﻭﺍﻷﻤﺭﺍﺽ ﻭﺍﻟﻤﺨﺘﺹ ﺇﺨﺘﺼﺎﺼﻲ ﻨﺎﺠﺤﺔ ﻓﻲ ﻭﺠﻭﺩ ﺨﺒﺭﺓ ﺒﺎﻟﺭﺸﻑ ﺍﻟﺩﻗﻴﻕ ﻭﺍﻟﺘﻨﺴﻴﻕ  ﺒﻴﻥ 
  .ﺍﻟﺴﺭﻴﺭﻱ
 NI YGOLOTYC NOITARIPSA ELDEEN ENIF FO ELOR EHT
 ETATS MUOTRAHK NI  SNOISEL REVIL LACOF FO SISONGAID
 sirdI deeslEdawA nishomlEdbA dilahK  
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1-1. INTRODUCTION 
 
Medicine is an ever changing science. As new techniques developed, 
these will have an impaction on diagnostic and treatment methods. 
In recent years advances in radiological investigations cut the way to 
diagnosis, however this is not enough; it should be supplemented by other 
investigation in our field of pathology. A number of entities, present as 
focal liver lesions, including cysts, abscesses, benign liver nodules, 
primary and metastatic malignancies (HANS popper society symposium 
MARCH 25, 2007). 
Beyond any shadow of doubt focal liver lesions detected by, 
ultrasound, or C.T scan, constitute a major stress to the patient, and a 
challenge to pathologist in term of verifying them. 
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1-2. LITERATURE REVIEW 
Find needing aspiration cytology (FNA): 
Cytological analysis of the liver involves the aspiration of cells from 
focal mass lesions or from brushing the lining of strictured intrahepatic 
ducts primarily for the purpose of determining the presence or absence of 
malignancy. Fine needle aspiration (FNA) of focal mass lesions can be 
performed percutaneously or with endoscopic ultrasound guidance.1'2 
intrahepatic ducts are brushed with the aid of endoscopic retrograde 
cholangiography.3'4  
Needle aspiration of the liver was performed as long ago as 1833 when 
Roberts and Biett reported its use in the treatment of hepatic abscesses 
and echinococcal cysts.5'6 Although the use of fine needles to obtain 
tissue for cytological diagnosis was first used by Lucatelio in 1895 [died 
in Lundquist 1971),7 it was a technique refined in the 1920s by Martin 
and Ellis at the Memorial Hospital in New York.8 Its utility in the liver 
was highlighted by Lundquist who published his experience using aspira-
tion cytology in the evaluation of neoplastic and non-neoplastic disorders 
of the liver.7'3'10 FNA biopsy is now the diagnostic procedure of choice 
for the diagnosis of focal mass lesions and is considered accurate and safe 
when performed and interpreted by experienced radiologists and 
pathologists.1'11"13 
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The diagnostic accuracy rate of FNA is reported at greater than 85% in 
most series.14 False negative FNAs are most often due to sampling error. 
Proper specimen processing and staining optimizes the preservation and 
presentation of the cells and is an important factor in reducing 
interpretation errors. Routine supplementation of FNA with a cell block 
of tissue fragments or core biopsy is better than either method alone, 
especially for benign neoplasms and poorly differentiated neoplasms that 
require ancillary studies;15-17  
Contraindications 
Contraindications for FNA of the liver are few but include a non-
correctable bleeding diathesis, the lack of a safe access route, and an 
uncooperative patient1,11For EUS guided FNA, gastrointestinal 
obstruction is an absolute contraindication because of the risk of intestinal 
perforation.18  
Complications 
With modern-day techniques, complications of FNA are uncommon. The 
most common complications include pain and haemorrhage14 The 
haemorrhage can be intraperitoneal, subcapsular, or intrahepatic and, if 
intrahepatic, can lead to haemobilia. There is a low risk of 
haematogenous dissemination of malignant cells after liver biopsy19'30 as 
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well as 'seeding" of the biopsy tract, complications that tend to be related 
to larger needle size.14'21 
Pre-biopsy assessment: 
Pre-biopsy assessment of patients undergoing FNA of the liver includes 
evaluation of the coagulation system to prevent excessive bleeding, 
generally complete blood count, prothrombin time and partial 
thromboblastin time.1 Patients who are receiving intravenous sedation 
should not eat at least 6 hours before the biopsy-1 Local anaesthetic is 
generally given down to the liver capsule. Discussing the procedure fully 
with the patient reduces patient anxiety, improves patient cooperation and 
increases the likelihood of a successful FNA procedure. 
Guidance systems  
Percutaneous computed tomographic (CT) or ultrasound (US) guidance 
are the guidance systems used for most liver FNAs.1'22"24 Endoscopic 
ultrasound guidance (EUS) is increasingly used for those lesions 
accessible through a transgastric approach, mostly in the left lobe.2'25"28 
Factors influencing the choice of the guidance system include the size, 
location and visibility of the mass, in addition to the experience and 
preference of the operator.141 Ultrasound provides real-time needle 
visualisation,  flexible patient positioning, variable imaging of the lesion, 
and is performed without ionising radiation. CT facilitates biopsy of 
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small, deep seated lesions not well demonstrated on ultrasound, CT more 
precisely demonstrates the anatomic relationships of a given lesion 
compared to US, improves the definition of tissue components and 
vascularity, and provides for accurate localisation of the needle tip 
immediately prior to sampling without the transmission of potential 
impediments such as drains, bone and gas. 
Sampling techniques: 
Percutaneous FNA endoscopic ultrasound-guided FNA and bile duct 
brushing Percutaneous FNA techniques generally vary depending on the 
location and size of the mass. Any mass lesion that is palpable can be 
directly aspirated without guidance in the usual manner for all palpable 
aspiration biopsies.  The most common techniques using guidance 
include individual puncture, coaxial biopsy, and tandem needle 
biopsy.1'11'29.   The coaxial biopsy technique is most commonly used. This 
technique uses a coaxial introducer needle through which FNA and core 
needle biopsy are performed with only one puncture into the lesion and 
without the need for repeat imaging. 
A concomitant core needle biopsy (CNB) following the FNA is 
recommended when at all possible. CNBs provide the necessary tissue 
architecture as well as readily available tissue for ancillary studies that 
aid  in providing a more specific diagnosis in many cases. Combined with 
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a preceding FNA, the accuracy in diagnosing focal mass lesions is 
significantly greater than that obtained with either method alone.15-17'30 
Endoscopic ultrasound-guided FNA {EUS-FNA} of liver masses is 
confined to those lesions visible and accessible via the stomach or 
duodenum. Lesions in the right lobe of the liver and hilum are assessed 
via the duodenum and distal stomach while those in the left lobe are 
accessed via the proximal and mid-stomach.31"34  
Bile duct brushing         
Biliary brushing cytology of suspicious biliary strictures is key to making 
an early diagnosis. Unfortunately, despite specificity of >95%, the 
technique has a low sensitivity ranging from 17-83%.3 Low sensitivity 
can be attributed to difficult access, desmoplasia, associated inflammation 
(stents, primary sclerosing cholangitis), scant specimen cellularity and 
poor cellular preservation and preparation.4'35'36 If sufficient cells are 
present and the cells are properly preserved and prepared for cytological 
evaluation (direct smears,  cytospins or liquid-based cytology (LBC)), the 
criteria for malignancy are universal: high N/C ratio,  prominent nucleoli, 
nuclear membrane abnormalities and hyperchromasia yielding 100% 
specificity for malignancy.37  LBC processing alone or in addition to 
direct smears has improved sensitivity and accuracy in some studies, but 
cytologists must be familiar with alterations to morphology and 
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background elements that may make malignancy appear more subtle in 
some cases.38"40 
Elevation in serum tumour markers CEA and CA19-9 have higher 
sensitivity for detecting carcinoma, but lower specificity (i.e. false 
positive tests).37 Adding digital image analysis35and fluorescence in situ 
hybridisation (FISH)41 show promise in improving the diagnostic value of 
biliary" brush cytology Specimen processing                  
 Specimen processing: 
It is desirable to obtain both smears and cell block preparations in all 
FNAs of the liver. Smears are from the aspiration part of the procedure 
using a small needle (<22 gauge) that provides a rapid means of 
evaluating the specimen, not only for cellular adequacy but frequently for 
diagnosis.  Multiple FNAs can be performed with minimal morbidity. If 
well-fixed, adequately smeared slides are difficult to obtain. The aspirate 
can be expressed into a preservative and submitted to the laboratory as a 
liquid-based specimen for processing by either the Thin Prep (Cytec 
Corporation, Marlborough, MA) or Sure Path™ (TriPath Imaging, 
Burlington, NC) methods. Cell blocks are made from FNA rinsings, any 
tissue fragments that are obtained, and dedicated CNBs using a spring 
loaded 18-20 gauge CNB gun such as the ASAP Biopsy System 
(Meditech/Boston Scientific Corp. Watertown, MA) or the Coaxial 
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Temno Biopsy System [Allegiance Health-care Corp, McGaw Park, IL). 
This material provides formalin fixed, paraffin embedded tissue sample 
from which special stains and immunohistochemical studies can be 
readily obtained. It also provides, in many cases, the architecture 
necessary for a specific diagnosis, particularly in benign liver lesions. 
CNB specimens can also be used for rapid interpretation by touching the 
core to a glass slide in a touch prep fashion.42  
Despite the presence of thick, three-dimensional tissue fragments and the 
probability of some air-drying artefact due to the inherent time delay in 
preparing the slide, architectural clues may still be readily apparent for 
rapid diagnosis. 
The cytopathologist is an important part of the overall team approach to 
FNA of the liver. The presence of a cytopathologist at the time of the 
FNA increases the overall accuracy of the procedure.13'17'43 The time of 
the actual biopsy, when additional tissue is still readily available, is the 
time to evaluate the specimen for adequacy and to triage the tissue for 
special studies such as flow cytometry or electron microscopy studies. If 
a cytopathologist or cytotechnologist is not available to assist in the 
preparation of the specimen, it is imperative that the radiologist learn how 
to make proper smears.  
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The most cellular specimen is useless if inadequately prepared for 
optimal interpretation.     
Tumour classification: 
The most recent WHO classification of tumours of the liver is presented 
in Table JU-44 Correct diagnosis is imperative for proper patient 
management. Pyogenic abscesses are typically drained,45'46 and smaller 
tumours are being treated with ablation techniques such as alcohol and 
thermal ablation-47 Chemotherapy and radiation protocols require a tissue 
diagnosis and targeted gene therapy is under investigation.45-411 
Normal morphology: 
The liver is a complex organ with functional lobular units of hepatic 
parenchyma anchored by portal tracts containing branches of the hepatic 
artery, hepatic portal vein and bile duct. Sinusoids are lined by a 
discontinuous layer of endothelial cells that separate hepatic plates of 1-2 
cells thick and that terminate in the central vein. Sinusoidal endothelial 
cells differ from vascular endothelial cells, unlike the endothelial cells of 
true vessels, sinusoidal endothelial cells are not supported by a basement 
membrane and do not express factor VIII,-Ulex europaeus or CD 34.50 
Transformation of sinusoids with the acquisition of these properties leads 
to capillarisation or the sinusoids, changes that are exploited in both 
histological and cytological evaluation for diagnosis. 
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In order to appreciate an abnormality in liver FNA, it is imperative that 
the cytopathologist understands the components of the normal liver. 
Table 1: WHO histological classification of tumours of the liver and 
intrahepatic bile ducts 
1) Epithelial tumours:  
Benign: 
Hepatocellular adenoma (liver cell adenoma). 
Focal, nodular hyperplasia. 
Intrahepatic bile duct adenoma. 
Intrahepatic bile duct cystadenoma. 
Biliary papillomatosis. 
Malignant: 
Hepatocellular carcinoma (liver cell carcinoma). 
Intrahepatic cholangiocarcinoma (peripheral bile carcinoma). 
 Bile duct cystadenocarcinoma.  
Combined hepatocellular and cholangiocarcinoma.   
Hepatoblastoma. 
Undifferentiated carcinoma. 
2) Non-epithelial tumours: 
 Benign: 
Angiomyolipoma. 
Lymphangioma and lymphangiomatosis  
Haemangioma. 
Infantile haemangioendothelioma. 
Angiosarcoma. 
Embryonal sarcoma (undifferentiated sarcoma).  
Rhabdomyosarcoma. 
Others. 
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3) Miscellaneous tumours 
Solitary fibrous tumour. 
Teratoma.  
Yolk sac tumour (endodermal sinus tumour). 
Carcinoma. 
Rhabdoid tumour. 
Others. 
4) Haemopoietic and lymphoid tumours. 
Secondary tumours.  
? Epithelial abnormalities: 
- Liver-cell dysplasia (liver cell change). 
- Large cell type (large cell change). 
- Small cell type (small cell change). 
Dysplastic nodules (adenornatous hyperplasia). 
- Low-grade.  
- High grade [atypical adenomatous hyperplasia). 
? Bile duct abnormalities: 
- Hyperplasia (bile duct epithelium and peribiliary glands). 
- Dysplasia (bile duct epithelium and peribiliary glands). 
- Intraepithelial carcinoma (carcinoma in-situ). 
5) Miscellaneous lesions:  
Mesenchymal hamartoma. 
Nodular transformation (nodular regenerative hyperplasia).   
Inflammatory pseudotumour. 
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Cytological findings of normal liver: 
The normal hepatocyte is a large polygonal cell with: 
• Abundant granular cytoplasm 
• One or two round to oval, centrally placed nuclei 
• Even chromatin pattern and occasionally prominent nucleoli 
• Generally appear as small clusters. 
 • Larger flat sheets with irregular jagged edges without endothelial cell 
wrapping or Single cells. 
Benign bile duct epithelial cells present as: 
• Varying sized flat monolayered sheets of epithelial cells  
• On-edge or in small acinar structures or groups 
• Smaller than benign hepatocytes 
• With round regular nuclei 
• Inconspicuous nucleoli 
• Less abundant cytoplasm than hepatocytes.  
Endothetial cells of sinusoidal spaces and Kupffer cells are rarely 
appreciated in benign lesions. 
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Pigments: 
Intracytoplasmic pigments in cytoloty preparations differ in appearance 
depending on the stain.  Lipofuscin constitutes the debris of intracellular 
lysosome breakdown, appears as a fine golden, granular, relatively non-
refractile pigment in alcohol fixed, Papanicolaou (PAP) stained smears 
and is typically concentrated around the nucleus. This pigment is 
generally very common in the FNA of older adults and its absence should 
increase suspicion of a neoplasm on FNA of a mass lesion. Lipofuscin 
will stain darkly with a Fontana Mason stain creating a potential 
diagnostic pitfall with a metastatic melanoma.51 
 
Photo 1: Normal hepatocytes. Benign hepatocytes demonstrate a polygonal shape, abundant 
granular cytoplasm focal steatosis and 1-2 round to oval centrally placed nuclei, 
with an even chromatin pattern and small nucleoli (Smear, PAP). 
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Bile pigment is produced by hepatocytes and is virtually pathognomonic 
of hepatocellular carcinoma when recognised within malignant cells. Bile 
appears as coarse, irregular, rather amorphous, non'refractiie green to 
golden brown globular intra-cytoplasmic and extra-cytoplasmic deposits 
on Papanicolaou stain. With Giemsa-Romanowsky stain, bile has a dark 
green to black hue. The distribution of the pigment is dependent on the 
degree of cholestasis, with pools of bile within canalicular spaces 
apparent in cases of extrahepatic obstruction. 
Iron or haemosiderin is a coarse, brown-black refractile pigment with 
Papanicolaou stain. While FNA can confirm the presence of heavy iron 
overload, it cannot replace CNB for histology and biochemical analysis to 
answer the clinical question of haemochromatosis. Malignant hepatocytes 
lose their ability to retain iron, and in the setting of haemachromatosis 
induced cirrhosis, where reactive hepatocyte atypia  may be quite marked, 
it is helpful to use a special stain for iron like Prussian blue to highlight 
cells or clusters of cells without staining.52 
Non-neoplastic conditions: 
Steatosis. 
Fatty change in hepatocytes is common in many conditions in the liver 
especially toxic/metabolic injury such as with alcohol abuse. Steatosis 
can result in the radiological appearance of mass lesion leading to FNA.53 
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Fat may present in the form of macrovesicular steatosis, the most 
common form in which one or more large fat vacuoles fill the cytoplasm 
or microvesicular steatosis, in which multiple small lipid vacuoles 
expand.  
Amyloidosis: 
The deposition of amyloid in the liver can rarely cause the appearance of 
a mass lesion (amyloidoma) leading to FNA, Amyloid deposition in the 
liver is most often secondary to systemic diseases such as rheumatoid 
arthritis and plasma cell dyscriasias (multiple myeloma). Amyloid, 
regardless of type, is an extracellular amorphous hyaline material that has 
a pink or green waxy or glassy appearance on Papanicolaou stain, and a 
magenta. 
Cytological findings amyloidosis: 
• Amorphous glassy or waxy extracellular material 
• Rounded dense droplets on LBC 
• Pink to green staining on Papanicolaou; magenta on Romanowsky     
• Congo red stain is positive 
• Apple-green birefringence with polarisation. 
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Splenosis: 
Ruptured splenic tissue following trauma or splenectomy can result in 
implantation or auto-transplantation of splenic tissue in the peritonea! 
cavity and even within parenchymal organs like the liver mimicking a 
neoplastic process, including hepatocellular carcinoma and especially 
metastatic malignancy given the typical multiple implants.55'56 Although 
most patients are asymptomatic, these mass forming lesions are picked up 
incidentally and may be investigated by FNA. Smears that are cellular 
and well-preserved recapitulate the normal spleen demonstrating a 
mixture of normal haemopoietic cells in a bloody background supported 
by a reticular network57. Lymphoid dominant FNAs, however, introduce 
small blue cell tumours into the differential diagnosis including small cell 
lymphoma and small cell carcinoma. An important clue to the diagnosis 
is a history of splenectomy and/or trauma. 
Cytological findings hepatic splenosis: 
• Benign appearing haemopoietic cells: lymphocytes and neutrophils 
• Lymphoid follicle 
• Reticular network holding aggregates of cells together 
• Bloody background. 
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Extra medullary haemopoiesis:  
Extra-medullary haemopoesis (EMH) is normal only within the first few 
weeks of life. After this point, EMH or myeloid metaplasia is an 
abnormal condition in which the liver attempts to produce the deficient 
blood cells that results when the normal bone marrow has been replaced 
by non-functioning tissue such as fibrosis in myeloproliferative diseases. 
EMH is also commonly associated with hepatoblastomas and hepatic 
angiosarcomas. EMH is often first considered with the recognition of 
megakaryocytes, large cells with abundant granular cytoplasm and 
lobulated nuclei. These cells are associated with normoblasts, red cell 
precursors, small cells with round, central pyknotic nuclei and dense 
eosinophilic cytoplasm, and myelocytes, slightly larger cells than 
normoblasts but smaller than megakaryocytes, a central round nucleus 
and granular cytoplasm.58 
Infection:  
Abscess formation in the liver is often suspected radiologically from the 
characteristic double target sign on computed tomography;  however, 
organised abscesses can mimic hepatic tumours leading to FNA.53 
Pyogenic abscess is the most common and percutaneous biopsy Is 
performed for tissue confirmation, culture and drainage-45'59 FNA is an 
acceptable means of diagnosis for all abscess sizes, but for therapeutic 
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drainage, FNA is recommended only for small abscesses <50 mm; larger 
abscesses require percutaneous catheter drainage for complete 
management.45 Smears are dominated by nonspecific acute inflammatory 
cells and cellular debris. Cultures are helpful for identification of 
bacterial organisms. 
Amoebic abscess is 10 times more common in men than in women and is 
rare in children.60 The distinction between pyogenic and amoebic abscess 
is important for both therapy and prognosis. Pyogenic abscesses have a 
20-60% morbidity due to an association with systemic infection, the 
tendency to produce multiple liver abscesses and an association with an 
older patient age.61Amoebic abscesses tend to occur as solitary liver 
masses in young patients, rarely require drainage and respond to metro-
nidazole therapy-60'61 Most patients with hepatic amoebiasis do not 
demonstrate intestinal symptoms, but hepatomegaly with point tenderness 
over the liver, below the ribs or in the intercostal spaces are typical 
presenting symptoms.60 Identification of organisms in aspiration fluid of 
hepatic abscesses is uncommon and diagnosis rests on the constellation of 
presenting symptoms, high risk factors, typical radiological findings of a 
solitary right lobe mass and positive serum antibodies which are present 
in 70-80% of patients.60 The single cell trophozoites of E. histolytica with 
round nucleus, condensed peripheral chromatin and central small 
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nucleolus with foamy cytoplasm resemble histiocytes and can be easily 
overlooked. 
Other infectious organisms may be recognised by unique characteristics 
such as the 'sulphur granules' of actinomyces and 'anchovy paste' smears, 
echinococcal booklets or scolices or laminated cyst wall in hydatid 
disease.46 
Granulomatous inflammation may be related to infection such as with 
fungal or acid fast organisms, but the presence of granulomata in a liver 
FNA is in no way diagnostic of an infectious aetiology. The presence of 
granulomata may be related to many conditions including primary 
hepatobiliary disorders, sarcoidosis, and tumours such as lymphoma and 
metastatic carcinoma. Hepatic sarcoidosis is one of the most common 
causes of non caseating granulomata of the liver.62 Cytologically granulo-
mata are composed of clusters of epithelioid histiocytes with oval to 
elongated, sometimes twisted nuclei and visible but indistinct, non-
phagocytic, cytoplasm. Special stains such as Crocott methenamine silver 
(GMS) and Ziehl Neelsen (ZN) for acid fast bacilli (AFB) can be 
performed on smears but are easier to perform on cell block preparations. 
Bile duct hamartoma: 
Bile duct hamartoma may present as a mass lesion mimicking a 
neoplasm, and as a result, may be encountered on FNA.63 
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This lesion is often aspirated at the time of diagnostic EUS-FNA of 
pancreatic masses, so care must be taken to distinguish gastro intestinal 
contamination from bile duct epithelium as a means of ensuring the 
aspirate is representative of the lesion. Smears contain a predominant 
population of benign appearing bile duct epithelial cells often in the form 
of flat mono-layered sheets of glandular cells with small uniformly 
spaced round nuclei. Luminal edges with scant but visible non mucinous 
cytoplasm are present. Benign hepatocytes are uncharacteristically few or 
absent as would be expected for a benign hepatic lesion such as focal 
nodular hyperplasia. Aspirates of bile duct adenoma have a similar 
appearance. Cell block preparations are helpful in rendering a diagnosis. 
Cytological findings: bile duct hamartoma adenoma: 
• Benign appearing glandular epithelium, often in flat mono-layered 
sheets. 
• Round, uniform, evenly spaced nuclei. 
• Scant but visible, non-mucinous cytoplasm. 
• Uncharacteristically few to no hepatocytes in the background. 
Mesenchymal hamartoma: 
Hepatic mesenchymal hamartoma is a benign mass forming lesion of 
malformed bile ducts and myxoid mesenchyme diagnosed in mostly male 
(70%) infants and children less than 5 years of age with rare cases 
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reported in adults.64’65 The aetiology is unclear with theories ranging from 
congenital plate abnormality to true neoplasm. These typically predomi-
nantly cystic masses are usually resected in childhood and complete 
resection is curative. Although serological tumour markers are usually 
normal, elevated AFP and atypical FNA cytology have been reported to 
lead to a preoperative diagnosis of hepatoblastoma, the primary tumour in 
the differential diagnosis.12'66 
Reports of the cytological features are few12'67'68 FNA produces scant 
smears composed of a loose myxoid mesenchymal stroma with benign-
appearing spindle cells and sheets of benign glandular epithelium that 
reflects the histology of disorganised loose myxoid mesenchymal tissue 
surrounding variably sized benign bile ducts and occasionally 
hepatocytes. Pseudocysts occur in the mesenchyme and are not lined by 
epithelial cells. Extramedullary haematopoesis may be noted. The 
patient's young age, male gender, cystic radiological appearance and 
benign-appearing myxoid spindled and glandular cell proliferation should 
lead to the correct diagnosis. 
Cytological findings: mesenchymal  hamartoma: 
• Benign appearing glandular epithelium, often in flat monolayered sheets 
• Myxoid stroma 
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• Benign appearing spindled cells 
• Variable number of benign hepatocytes. 
Inflammatory pseudotumour  
Inflammatory pseudotumour (IPT) of the liver is an uncommon, benign, 
mass-forming proliferation of mixed inflammatory cells and histiocytes 
dominated by polyclonal plasma cells infiltrating a stroma of fibroblasts, 
myofibroblasts and collagen. These lesions are reported in patients of 
both genders, but mostly males (70%), and all ages from infancy to the 
eighth decade.69 The heterogeneity of these proliferations has led to many 
synonymous names, including plasma cell granuloma, inflammatory 
myofibrohistiocytic proliferation, fibroxanthoma and inflammatory myo 
fibroblastic tumour. Although some reports of locality and association 
with the Epstein-Barr virus have supported a neoplastic process in some 
cases70  
The aetiology in most hepatic IPT is inflammatory or infectious.71 More 
recently, pseudotumour is considered to be part of the IgG4 related 
sclerosing disease, often associated with autoimmune pancreatitis.72,76 
These lesions are benign, but rare cases of biological aggressiveness and 
malignant transformation have been reported.77 
Diagnosis by FNA is challenging due to the non-specific and variable 
nature of the mixed inflammatory sample 78'79 Smears are often cellular 
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composed of cohesive networks of spindle mesenchymal cells enmeshed 
with mixed inflammatory cells and foamy (xanthomatous) histiocytes that 
also populate the background.  
Plasma cells are usually prominent and neutrophils and eosinophils are 
minor components. The spindle cell component may also be dominant 
and single spindle cells are noted. Atypia, especially in the mesenchymal 
cells and histiocytes, can be a pitfall.78 The differential diagnosis includes 
spindle cell lesions of the liver including gastrointestinal stromal tumours 
and sarcomas. The typical high cellularity of the inflammatory 
component should preclude a false positive interpretation. 
CytologicaI findings: inflammatory pseudotumour.  
• Mixed inflammatory proliferation 
• Numerous plasma cells and foamy histiocytes 
• Benign appearing spindled cells in cohesive groups.  
Ciliated hepatic foregut cyst  
This rare hepatic cyst is an embryological remnant of the foregut that 
differentiates along bronchial lines to form a cyst lined by pseudostratfied 
columnar epithelium. These cysts' are predominantly unilocular, 
subcapsular and less than 4cm.80 Except for its hepatic location, the 
cytology is identical to' a bronchogenic cyst.81 
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Cytological findings:  ciliated hepatic foregut cyst:   
• Thin to mucoid cyst fluid. 
• Ciliated columnar cells. 
• Mucous cells. 
• Generally few to no hepatocytes. 
Diagnostic pitfall ciliated hepatic foregut cyst: 
Mucoid contents and mucous cells could lead to diagnosis of 
hepatobiliary cystadenoma. 
Benign neoplasms: 
Angiomyolipoma: 
 This benign mesenchymal neoplasm is purported to arise from the 
perivascular epithelioid cell (PEC) and has been classified as a PEComa, 
one of several benign, neoplasms of the tuberous sclerosis complex.82 It is 
composed of varying combinations of fat, smooth muscle and vessels. 
When the fatty component is readily recognised radiologically, 
histologically and cytologically, the diagnosis is relatively 
straightforward, In fact, it is usually the paucity of fat in the neoplasm 
that leads to a diagnostic dilemma and subsequent FNA83'84 the 
histological and cytological features of this tumour are similar in the liver 
and the kidney. Diagnostic difficulties on cytology arises when the fatty 
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component is scant or focal and not sampled, and when solid epithelioid 
areas predominate.85’86Cell block preparations provide not only 
architectural clues, but tissue for ancillary testing. Positive staining with 
HMB-45 confirms the diagnosis.87Other immuno-histochemical markers 
that label this neoplasm include viementin, desmin, actin and endothelial 
markers such as Factor V111.88 
Cytological findings: angiomyolipoma: 
• Interlacing complex of smooth muscle, fat and blood vessels. 
• Immunocytochemical stain for confirmation: HMB-45. 
Diagnostic pitfalls angiomyolipoma:  
• Smooth muscle may dominate smears and can demonstrate atypia. 
• Solid epithelioid areas may be dominant, can produce significant atypia 
and can lead to false positive interpretations. 
Haemangiomas:  
Haemangiomas constitute the most common benign neoplasm of the 
liver. They occur in all ages and both genders. These mass lesions are 
generally small and asymptomatic, but can occasionally be large (>5cm) 
and cause symptoms. Although radiological diagnosis has improved with 
enhanced imaging techniques, most are found incidentally during work-
up for other conditions, including staging of malignancy, and can be 
26 
 
difficult to distinguish from a metastasis radiologically.89'90 Cytologically, 
FNA smears are frequently considered unsatisfactory or non-diagnostic 
due to either the aspiration of blood only, or the presence of nonspecific 
appearing connective tissue. It is this loose, rather than dense fibrous type 
connective tissue and smooth muscle fragments associated with blood 
and few to no back ground hepatocytes that should alert the pathologist to 
the diagnosis of haemangioma in the proper clinical setting. Cell block 
preparation of a core needle biopsy is crucial in making a specific 
diagnosis. 
Cytological findings; haemangioma:  
• Bloody, scantily cellular smears. 
• Coils of loose connective tissue and smooth muscle. 
• Generally few to no hepatocytes. 
• Smears commonly non-diagnostic; specific diagnosis dependent on cell 
block. 
Hepatobiliary cystadenoma:  
This benign cystic tumor is a solitary, multiloculated cystic neoplasm of 
the liver that is histologically similar to cysts found in the pancreas and 
ovary. Women are almost exclusively affected. These neoplasms can 
become very large and patients usually present with abdominal pain. The 
neoplasm does not communicate with the biliary system. The locules are 
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filled with fluid that varies from thin and clear to bloody and turbid-The 
cyst lining is mucinous but the cells can become attenuated or denuded 
from fluid pressure. The characteristic subepithelial ovarian type stroma 
is not typically sampled on FNA which has been rarely reported.91'92 The 
cytology is similar to mucinous cystic neoplasm of the pancreas, often 
scantily cellular and nondiagnostic on its own. Cyst fluid with foamy 
histiocytes and mucinous epithelium, even if very scant, are sufficient for 
diagnosis in the appropriate clinical setting. Recognition of the malignant 
counterpart, hepatobiliary cystadenocarcinoma, is possible if the cytology 
is overtly malignant, but less than malignant cytology does not exclude 
malignancy and, as such, the treatment of choice is total resection.92 
Cytological finding: hepatobiliary cystadenoma: 
• Thin to mucoid cyst fluid. 
• Foamy histiocytes. 
• Benign appearing mucinous glandular cells. 
• Sub-epithelial ovarian type stroma is not aspirated. 
• Generally few to no hepatocytes. 
Benign  hepatocytic nodules or masses: 
Benign hepatocytic mass-forming proliferations, including dysplastic 
nodule (DN), focal nodular hyperplasia (FNH) and hepatocellular 
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adenoma (HCA), share in common many cytological features and 
distinction between them on smear cytology alone is difficult if not 
impossible.93 As such, the cytological features of these lesions will be 
discussed together. In addition, all of these lesions share in common the 
same differential diagnosis, namely well-differentiated hepatocellular car-
cinoma.  
Taking into consideration the clinical and radiological presentation of the 
patient in conjunction with the cytohistology will typically lead to the 
correct interpretation. 
Dysplastic nodule is a diagnostic consideration in the clinical setting of a 
mass in a cirrhotic liver clinically suspicious for hepatocellular 
carcinoma.  The nomenclature of dysplastic nodules has changed over the 
past decade and now is a term used for macroregenerative nodule, 
adenomatous hyperplasia and other terms used to describe nodules in the 
liver that are grossly and histologically larger than the surrounding 
cirrhotic nodules [usuallyl-3cm).94 Dysplastic nodules are sub-classified 
as low-grade dysplasia (macroregenerative nodule) and high-grade 
dysplasia (small cell dysplasia), high-grade dysplasia. 
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Table 8.2 Features typical of benign hepatic nodules versus well-differentiated 
hepatocetlular carcinoma 
 Benign hepatics nodules  
Clinical DN, Low grade HCA FNH WDHCC 
Gender Males  and Females Female > males Females > males Males > females 
Age Adults 15 – 45 years All ages, mostly 
adult women 
Adults 
Cirrhosis Yes No Yes No 
Other Oral 
contraceptive 
use; glycogen 
storage diseases
Hepatic 
haemangiomas
Alcohol abuse, 
viral hepatitis
Radiology Nodule size 0.8 – 3 cm nodules 5-15cm, solitary 
mass 
< 5 cm mass, 
stellate scar
> 1 cm nodule
Serology AFP Not elevated Not elevated Not elevated Elevated 
Cytology
Hepatocytes Irregular shaped clusters without peripheral 
transgressing endothelial cells; single cells; bland 
appearing large hepatocytes ± cytoplasmic 
glycogen and/or fat; round regular nuclear 
without prominent nucleoli; scattered large 
dysplastic cells.  
Peripherally wrapping 
and transgressing 
vessels; monomorphic 
small hepatocytes 
nucleoli, often macro; 
hyaline globules. 
Bile ducts Yes No Yes No 
Ancillary 
tests 
Reticulin Present, highlights normal 1-2 cell thick hepatic 
plates  
Decreased to absent; 
highlights >3 cell thick 
plates when present 
AFP Negative Negative Negative Present (30-40%) 
Glypcian-3 Negative Negative (focal 
weak positive)
Negative Positive 
CD34 Negative Positive 
periportal/septal
Negative Positive diffuse
 
WDHCC: well-differentiated hepatocellular carcinoma. DN: dysplastic nodule. HCA: 
Hepatocellular adenoma. FNH: Focal nodular hyperplasia. AFP: alpha-fetoprotein.  
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Photo 2: Focal nodular hyperplasia hepatocytes bile ducts and fibrous tissue in a 
disarray characterize this by endothelial cells. proliferating or  arborising 
vessels (transgressing endothelial cells) are focal at best reactive and 
proliferative . 
 
 
 
 
 
 
 
 
Photo 3: Hepatocellular adenoma. Medium sized vessels punctuating hepatic 
parenchyma without bile duct epithelial cells characterizes this benign 
neoplasm from other benign, hepatocytes nodules (cell block, H&E). 
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Or in irregularly shaped, jagged edged clusters without associated 
peripherally wrapping endothelial cells proliferating or arborisig vessels 
(transgressing endothelial cells are focal at best. 95-97   
Bile duct epithelial cells may also be present in FNH or by contamination 
from the edges of other nodules, and their presence should greatly raise 
one's threshold for a malignant diagnosis.                                             
Cellular features of reactivity include an apparent hepatocytes 
pleomorphism rather than monomorphism, an increased number of 
binucleated cells which tend to be decreased in hepatocellular carcinoma, 
a relatively low nuclear to cytoplasmic ratio, smooth nuclear membranes 
and prominent but not large nucleoli.  Large cell change seen in low 
grade dysplastic nodules are dysplastic hepatocytes recognised    by their 
enlarged atypical nuclei and sporadic placement in a background of 
otherwise typically reactive appearing hepatocytes yielding a 
polymorphous and pleomorphic smear pattern. 
Small cell dysplasia present in high-grade dysplastic nodules is extremely 
difficult to distinguish from the monomorphism of well-differentiated 
hepatocellular carcinoma but should be considered with small high N/C 
ratio hepatocytes-without-an abnormal vascular pattern of peripherally 
wrapping endothelial - cells or transgressing endothelial cells.93                     
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Due to the overlap in the components of these various benign entities on 
smear cytology, cell blocks as well as radiological and clinical correlation 
are crucial in making a specific diagnosis- The smallest fragment of 
tissue may be all that is necessary to render a specific diagnosis. This 
readily available tissue may be used for the few ancillary tests that can 
aid in the-benign versus malignant differential diagnosis. 
Ancillary tests: 
Cell block preparations of small tissue fragments or CNBs currently offer 
the best method of distinguishing between benign and malignant 
hepatocytic proliferations. Not only is the architecture available, but 
tissue is readily available for ancillary studies. The reticulin stain 
demonstrates a maintained 1-2 cell hepatic plate framework in all benign 
lesions even if in disarray and the sinusoids are not apparent98. Alpha-
fetoprotein (AFP) staining is only focally and weakly positive at best in 
benign hepatocytic proliferations, but a negative stain does not exclude 
HCC. Serum levels of AFP >400ng/mL are highly associated with the 
presence of HCC.87 The immunostain hepatocyte paraffin 1 (HepPar 1)99 
does not distinguish between benign and malignant hepatocytes. 
Glypican-3, (GPC3), is an oncofetal protein shown to be over-expressed 
in HCC and can be detected in the serum and tissue of patients with HCC 
but not benign hepatic lesions, with the rare exception of weak focal 
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staining in HCA.100-104 Studies with immunohistochemistry staining with 
anti-GPC3 antibody, have indicated great promise in the distinction 
between benign and malignant hepatocytes on histological sections,105-106 
and on cytological material.107 Immunostains that attempt to highlight 
capillarisation of the sinusoids such as CD34108 factor VIII109 and laminin 
can also be helpful. CD34 can show significant sinusoidal positivity in 
HCA, and this can present a pitfall in the interpretation of small tissue 
samples in cell block. 
Molecular studies and image analysis studies have attempted to 
discriminate between benign and malignant hepatocytes. Flow cytometry 
has shown promise,110 but there is still, significant overlap in the ploidy 
patterns of benign and malignant processes. Proliferating cell nuclear 
antigen (PCNA) appears to have a better specificity in separating the two 
entities, however, there is still overlap in the PCNA positivity of small 
cell liver dysplasia and grades I and II hepatocellular carcinoma.111-112 
These methods, as well as polymerase chain reaction, FISH,113 albumin 
messenger RNA,114 and a combination of parameters115 continue to be 
investigated. 
Cytological findings: benign hepatocytic nodules [DN, FNH, HCA]  
• Hepatocytes in jagged irregular clusters and singly. 
• No peripherally wrapping endothelial cells. 
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• Clusters may have focal transgressing endothelial cells. 
• Mild pleomorphism of cell and nuclear size; sporadically placed large 
atypical cells (dysplastic hepatocyte large cell change). 
• Many binucleated hepatocytes. 
• Variably prominent nucleoli but no macroeosinophilic nucleoli. 
• Cytoplasm is generally abundant and granular but may show fatty 
change, lipofuscin pigment or iron deposition.   
• Reticulin stain will show retained 1-2 cell layer framework on cell 
block. 
Diagnostic pitfalls benign hepatocytic nodules (DN, FNH, HCA) 
• Marked steatosis may result in false negative reticulin stain. 
• AFP and glypican 3 are negative; weak focal staining may be noted. 
• CD34 generally does not stain sinusoids; focal strong staining in HCA. 
Hepatocellular carcinoma: 
Hepatocellular carcinoma (HCC) is the fifth most common cancer 
worldwide, and its incidence is increasing due to the widespread 
prevalence of hepatitis B and C virus infections, especially in Europe and 
the USA.116'117 HCC almost always develops in the setting of cirrhosis, 
most often secondary to alcohol but with an incidence about 15% in 
patients with hepatitis C. The risk in patients with hepatitis C increases 
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with concomitant metabolic injury from alcohol, obesity, diabetes and 
hepatitis B virus.35 The prognosis of patients is poor for large 
symptomatic lesions, so early detection is key to long-term survival. 
Early detection of small, non-vascularly invasive tumours can improve 
survival from <10% to >50%.118'1I5 In that regard, high-risk patients are 
routinely screened for suspicious nodules (≈ 1 cm) and FNA with CNB is 
typically used for diagnosis. Treatment options include liver 
transplantation for good surgical candidates, and percutaneous ablation 
for non-surgical candidates.47'118'119 Percutaneous ablation techniques 
include ethanol injection and thermal ablation using radiofrequency, laser 
or microwave energy.47 
The cytohistological diagnosis of hepatocellular carcinoma falls into two 
main categories; low-grade (well-differentiated) and high-grade 
(moderately and poorly differentiated) tumours. 
Well-differentiated hepatocellular carcinoma: 
 Well-differentiated hepatocellular carcinoma is a tumour that looks 
hepatocytic but does not look obviously malignant. Given that the tumour 
cells of well-differentiated hepatocellular carcinoma are so similar to 
normal liver, the smear pattern proves to be a critical feature in evaluating 
this tumours.95-97'120 
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The three basic smear patterns are:  
(1) The cohesive, nested and trabecular pattern with peripherally 
wrapping endothelial cells. 
 (2) Loosely cohesive sheets with transgressing endothelial cells, or 
vessels. 
 (3) The dispersed small cluster-single cell pattern, without a recognizable 
vascular pattern. 
The most specific pattern is the peripherally wrapping endothelial 
pattern.95'96This pattern is one in which the - endothelial cells of the 
sinusoids wrap around smooth edged, rounded nests and thickened 
hepatic trabecular. The endothelial cell nuclei may not be apparent in 
every plane of focus, but the presence of even one or two nuclei at the 
edge is sufficient.   Although this pattern is only found in less than half of 
tumours,95'96 when present, it has been found to be very specific for the 
diagnosis of hepatocellular carcinoma and proves to be one of the most 
important diagnostic clues in separating reactive non-neoplastic and. 
benign neoplastic proliferations from well-differentiated hepatocellular 
carcinoma.96'97 
The other pattern of endothelial proliferation has been termed 
transgressing,96 arborising or central.95A complex network of small 
vessels is present in a loosely cohesive sheet of hepatocytes. The 
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appearance is similar to proliferating capillaries in other processes, such 
as granulation tissue, suggesting that the endothelial cells are associated 
with basement membranes, a feature of abnormal sinusoids as in 
hepatocellular carcinoma.121This pattern is not as specific for hepatocellu-
lar carcinoma as the peripherally wrapping endothelial pattern, but is 
highly associated with the presence of hepatocellular carcinoma, It is 
rarely seen in cases of cirrhosis and hepatitis.96 
The dispersed small cluster-single cell pattern is completely non-specific 
and may be seen in all types of hepatocellular proliferations. The smear 
pattern will not be helpful in all cases and other features need to be 
assessed. 
Individual cellular features that support a malignant diagnosis include the 
presence of cellular monotony with a uniformly elevated nuclear to, 
cytoplasmic ratio, e.g. all of the cells appear to have the same degree of 
atypia one to the other (Macroeosinophilic nucleoli and intracytoplasmic 
hyaline globules). 
Cell blocks of small 'tissue fragments and CNBs provide help in assessing 
the hepatic plate architecture and capillarisation of the sinusoids, either 
on routine H&E stain or with ancillary tests if necessary. 
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Photo 4: Well-differentiated hepatocellutar carcinoma. (A) The peripherally wrapping 
endothial cell pattern demonstrates the capillarised endothelial cells of sinsusoid 
wrapping around smooth edged, with nests and thickened hepatic trabeculae of 
hepatocytes (smear, PAP). (B) This pathognomonic feature is also demonstrated in 
cell block preparations (H&E). 
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Moderately to poorly differentiated hepatocellular carcinoma: 
High-grade hepatocellular carcinoma displays features of obvious 
malignancy, for example smears of high cellularity with cellular 
crowding and nuclear overlapping, nuclear membrane abnormalities, 
hyperchromasia and macronucleus, which are many of the same features 
used to assess malignancy in a histological preparation. Moderately 
differentiated hepatocellular carcinoma is readily recognised as malignant 
by the nuclear atypia and there is some evidence of hepatic 
differentiation, such as abundant granular cytoplasm. Poorly 
differentiated hepatocellular carcinoma is an obviously malignant tumour 
with little to no hepatic resemblance and as such difficult to distinguish 
from any other poorly differentiated tumour. 
 
Photo 5: Moderately-differentiated hepatocellular carcinoma.  This high grade hepatocellular 
carcinoma maintains some hepatic preservation while displaying obvious 
malignant features smear. 
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Smear patterns are equally important in the diagnosis of high-grade HCC, 
especially the peripherally wrapping endothelial pattern. The presence of 
peripherally wrapping endothelial cells around the smooth edged nests 
and trabeculae of cells supports the diagnosis of HCC.  The peripheral 
pattern is not a feature of metastatic renal cell carcinoma, a 
morphological mimicker of hepatocellular carcinoma, but the 
transgressing pattern is the most common pattern of that tumour both in 
the kidney and in metastatic deposits122. 
Although present in less than half of cases, the presence of bile 
production by malignant tumour cells is a relatively pathognomonic 
finding for the diagnosis of HCC.95'123  
A Hall's stain can be used to confirm the nature of the pigment as bile. 
The presence of intracytoplasmic mucin generally excludes 
hepatocellular carcinoma (except in the rare case of a combined 
hepatocellular-cholangiocarcinoma) and its presence should focus the 
differential diagnosis on adenocarcinoma. 
Hepatocellular carcinoma variants: 
Fibro-lamellar variant is a variant of hepatocellular carcinoma that 
generally occurs in young patients as a solitary mass in a non-cirrhotic 
liver that lends itself more readily to excision, thereby improving the 
prognostic outlook.124 It is a tumour associated with dense broad fibrous 
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bands and large malignant hepatocytes with an abundance of dense 
oxyphilic cytoplasm. The presence of abundant dense oxyphilic type 
cytoplasm often-with intracytoplasmic pale bodies, a deceptively low 
nuclear to cytoplasmic ratio and intranuclear inclusions are the key 
characteristic features on FNA cytology. Due to the dense fibrous stromal 
component of this tumour, smears may be paucicellular and malignant 
hepatocytes may be individual, single, and widely scattered. Peripherally 
wrapping endothelium is not a feature of this tumour, but transgressing 
endothelium has been observed.125 
The acinar cell variant is a morphological variant that presents a 
diagnostic challenge on cell block preparations. The frequently "back to 
back' acini give the appearance of an adenocarcinoma. There should be 
no mucin in the lumen of the acini or within the cytoplasm of the cells, 
and the acini should be separated by similarly malignant cells with no 
true cribriform architecture. Immunohistochemical stains will be helpful 
in establishing the correct diagnosis. 
The clear cell variant is characterised by the abundance of 
intracytoplasmic fat and/or glycogen and introduces clear cell tumours 
metastatic from other sites into the differential diagnosis, especially from 
the kidney, morphologically, the clear malignant hepatocytes are large 
polygonal cells with central nuclei, large nucleoli and abundant, clear, 
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vacuolated cytoplasm. These neoplasms can be impossible to distinguish 
from clear cell renal cell carcinoma. As mentioned above, the presence of 
the peripherally wrapping endothelial pattern is a finding that excludes 
renal cell carcinoma, but the transgressing pattern is not. Immunostains 
are usually required for diagnosis. 
Ancillary studies: 
As mentioned above under 'Benign hepatocytic nodules', one of the most 
helpful ancillary tests in the diagnosis of well-differentiated 
hepatocellular carcinoma includes the use of the reticulum stain.97-98,126,18  
The reticulum stain can be used on either smears or cell block 
preparations. An abnormal reticulum staining pattern, usually in the form 
of an absence of reticulum staining, is highly associated with the presence 
of hepatocellular carcinoma.'17'98'126 Small, very early well-differentiated 
HCC may retain the reticulum staining pattern and cannot reliably be 
distinguished from small cell dysplasia.127 Another pitfall in the 
interpretation of the reticulum stain is the presence of marked steatosis 
that can cause a false negative result.98 Positive staining with GPC3 also 
supports malignant over benign hepatocytes. An iron stain such as the 
Prussian blue stain can highlight the normal, haemosiderin laden 
hepatocytes bright blue leaving malignant hepatocytes that have lost their 
ability to retain iron unstained. 
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The basic immunocytochemical panel in the differential diagnosis of 
hepatocellular carcinoma and metastatic carcinoma, includes anti-
hepatocyte antibody HepPar-1 that gives a strong diffuse chunky staining 
pattern 123-130 MOC-31,131-133 GPC3,105'106 AFP, low (CAM 5.2) and high 
(AE1) molecular weight (MW) cytokeratin (CK), poly-clonal 
carcinoembryonic' antigen (CEA) and neprilysin (CD 10) staining, the 
latter two producing a canallcular staining pattern.134-136 The hepatocytes 
markers Hep-Par 1 and GPC3 do not have 100% sensitivity or specificity 
for the diagnosis of malignancy of hepatic origin, so these markers should 
be used in a panel of markers to support a the diagnosis of HCC. The 
endothelial cell marker CD34 stains the sinusoids diffusely indicating 
capillarisation of the sinusoids and supporting the diagnosis of 
hepatocellular carcinoma. AFP staining is helpful if positive, but a 
negative stain does not rule out HCC as only about 40% of HCC are 
associated with a positive stain.137 One must also keep in mind that AFP 
may occasionally be positive in reactive processes,138 so a positive stain 
does not in itself diagnose malignancy. As mentioned earlier, serum 
levels of AFP >400ng/mL are strongly associated with the presence of 
hepatocellular carcinoma, but not all tumours are associated with elevated 
levels, particularly the fibrolamellar variant.124 
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Cytological finding's: well-differentiated hepatocellular carcinoma: 
• Low-power smear pattern with smooth-edged clusters and thickened 
trabeculae with peripherally wrapping endothelial cells (pathognomonic). 
• Low-power smear pattern with more than focal loosely cohesive sheets of 
hepatocytes with transgressing vessels (highly suspicious finding). 
• Monotonous, uniform hepatocytic cell population with subtle malignant 
features. 
• Acinar formation in cell clusters. 
• Increased nuclear to cytoplasmic ratio compared to normal hepatocytes. 
• Macroeosinophilic nucleoli. 
• Reduced number of nucleated cells. 
• Background free of bile duct epithelial cells. 
• Reticulum stain demonstrates a loss of the normal 1-2 cell thick hepatic 
plate architecture. 
• Iron stain fails to stain tumour in cases of haemachromatosis. 
• Positive glypican-3 immunostaining; AFP.  
Cytological findings moderately to poorly differentiated hepatocellular 
carcinoma: 
• Peripherally wrapping endothelial smear pattern is virtually 
pathognomonic. 
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• Transgressing vessels are suggestive but cannot distinguish hepatocellular 
from renal cell carcinoma. 
• Presence of intra-cytoplasmic bile is pathognomonic. 
• Polygonal cells with central nuclei and prominent nucleoli. 
• with visible, granular to clear cytoplasm in moderately differentiated 
tumours; scant to no cytoplasm in poorly differentiated tumour. 
• Immunopheno type: low MW CK (Cam 5.2), polyclonal CEA, and CDI0 
(canalicular) HepPar-1 positive; AFP variable; high MWCK(AE1) 
negative.  
Cytological finding variants: 
Fibrolamellar hepatocellular carcinoma 
• Population of large hepatocytes singly and in loose clusters. 
• Smears may be paucicellular due to fibrosis. 
• Transgressing vessels may be seen, but no peripherally wrapping 
endothelial cells. 
• Deceptively low nudearto cytoplasmic ratio. 
• Large, variably atypical nuclei with prominent nucleoli and frequent 
intranuclear inclusions. 
• Cytoplasm is characteristically abundant and oncocytic appearing. 
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Acinar variant: 
• Back-to-back acini/rosettes of hepatocytes. 
• No mucin production. 
Clear cell Variant: 
• Cells with abundant vacuolated, clear cytoplasmic filled with glycogen 
and/or fat. 
Hepatoblastoma: 
Hepatoblastoma is the most common tumour of children with 75% 
occurring in males and 90% occurring before the age of 5 years.69 There 
is a strong association with familial adenomatous polyposis syndrome 
and Beckwith-Wiedemann syndrome.133 Patients generally present with 
an enlarging, often palpable mass that is usually single, lobulated and 
bulky.  Serum AFP levels are almost always elevated and serve as a use-
ful marker for recurrence and metastases.59  
Histologically, this tumour recapitulates the developing liver and may 
contain heterologous mesenchymal or epithelial elements. 
Hepatoblastoma are classified as either epithelial or mixed epithelial-
mesenchymal. The epithelial type consists of either immature embryonal 
and/or fetal hepatic epithelial cells; the mixed type typically contains both 
embryonal and foetal epithelial cells admixed with spindle cell mesen 
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chyme.94 Given this heterogeneity, the FNA smears of this tumour can 
have a varied appearance.140-141 -Smears of both types of hepato-blastoma 
are dominated by the epithelial cells. The fetal type cell resembles the 
normal hepatocyte but is generally smaller.   
The nuclei are central, round and bland appearing and the cytoplasm may 
contain fat, and glycogen. Unlike the embryonal cell type.142The 
embryonic cell is more primitive and undifferentiated with hyper 
chromatic nuclei and scant cytoplasm that may form rosettes and 
trabeculae142. Rarely the epithelial cells appear undifferentiated or 
anaplastic and resemble other small round blue cell tumours of childhood 
and are impossible to distinguish from neuroblastoma or Wilm's tumour 
on morphology alone.143-144  
The mesenchymal component, if present, presents as cellular spindle cell 
type mesenchyme, but heterologous elements may also be present 
including osteoid, cartilage, skeletal muscle and, particularly, extra-
medullary haematopoiesis.142 Amyxoid matrix has been described.145 
The primary differential diagnosis-rests most frequently between the fetal 
type Hepatoblastoma and hepatocellular carcinoma, and embryonal or 
anaplastic hepatoblastoma and other paediatric small round blue cell 
tumours.143 
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Photo 6: Hepatoblastoma (A)  The foetal  type  is composed of cells that resemble the normal 
hepatocyte but are generally smaller with central round and bland nucleoli (smear, 
diff-quik) (B) The embryonal type is composed of more primitive cells with 
hyperchromatic nucleoli and scant cytoplasm (smear, PAP) 
49 
 
Ancillary tests: 
Ancillary studies and clinic-pathological correlation are required. 
Hepatoblastoma will stain with high-molecular weight cytokeratin,146 
whereas tumour cells of most hepatocellular carcinomas do not.147Both 
tumours stain with low-molecular-weight cytokeratin (CAM 5.2).146 
Polydonal CEA. Stains hepatoblastomas with a variable and inconsistent 
canalicular and/or cytoplasmic pattern depending on the type of 
hepatoblastoma.145This stain will not distinguish hepatoblastoma from 
hepatocellular carcinoma but can help in the distinction between a 
primary and metastatic tumours. HepPar-1 positivity supports a hepatic 
primary over other small round blue cell tumours of non-hepatic 
origin,128-130-148 
Cytological finding hepatoblastoma:  
• Epithelial dominant smears. 
• Mesenchymal (spindle cell) component and/or heterologous elements, 
especially extramedullary haemopoesis and osteoid, relatively scant.                      
• Epithelial cells are either small hepatocytic (fetal type), smaller 
immature, pleomorphic cells (embryonal type) or smaller still 
undifferentiated blue cells (anaplastic type). 
• Epithelial cells form cohesive, crowded clusters, cords, ribbons or rosettes 
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• Immunophenotype: positive for low- and high-MW CK (CAM 5.2 and 
AE1), pCEA with variable canalicular/cytoplasmic staining, HepPar-1. 
Cholangiocarcinoma:  
Cholangiocarcinoma is an adenocarcinoma of the bile ducts that occurs 
predominantly in the non cirrhotic liver of the elderly population, most 
commonly of South-east Asia due to the high infestation with the liver 
fluke. Patients with primary sclerosing cholangitis (PSC) and cirrhosis 
due to hepatitis C are also at increased risk.69'94 These neoplasms are 
classified by their location as peripheral (intrahepatic), hilar (Klatskin 
tumour), extra-hepatic and intraductal types- All but the intraductal type 
form a firm, white-tan mass that can become quite large when 
intrahepatic, but is usually small in the hilar or extra-hepatic locations due 
to obstruction causing early detection.69 FNA is used to sample obvious 
masses while brush cytology is used to sample strictured or thickened 
ducts. EUS-FNA has been shown to add value to the diagnosis of hilar 
and extra-hepatic cholangiocarcinomas.33 While the principal criteria for 
the diagnosis of adenocarcinoma on FNA smears are relatively standard 
regardless of location, the interpretation of bile duct brushings requires 
more stringent set of criteria and a higher threshold for the interpretation 
of malignancy. This is due to the difficulty in obtaining a specimen of 
quality and quantity sufficient for a confident malignant diagnosis. 
51 
 
Sclerosis and inflammation inherent to the tumour or secondary to an 
underlying condition (PSC, stent placement,..etc.) contribute to a 
paucicellular sample and preparation artifact from obscuring blood, crush 
and air drying artifact limit optima Interpretation. Processing bile duct 
brushings in a liquid-based medium has shown improvement in 
diagnostic sensitivity and specificity. 
The most common histological appearance of cholangiocarcinoma is a 
low-grade, well- to moderately differentiated adenocarcinoma forming 
tubules and cribriform glands infiltrating a sclerotic stroma. FNA smears 
generally produce a readily recognisable adenocarcinoma but with 
nonspecific features compared to those metastatic from the upper 
gastrointestinal tract and lung. Smears are variably cellular and 
demonstrate irregular, variably sized sheets of atypical to malignant 
appearing glandular cells that resemble bile duct epithelium. 
Clusters of tumour cells may show cytoplasmic vacuolisation and focal 
mucin production. Cell block preparations are particularly helpful in this 
diagnosis because the characteristic common histological pattern 
described above may be recognised. 
Ancillary tests: 
A simple mucin stain demonstrating the production of mucin will define 
the neoplasm as an adenocarcinoma' and, with the rare exception of a 
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mixed Cholangiocarcinoma-hepatocellular carcinoma, exclude the 
diagnosis of hepatocellular carcinoma. The basic immunohistochemical 
panel discussed above under hepatocellular carcinoma will also help in 
this differential diagnosis. Distinguishing Cholangiocarcinoma from 
metastatic adenocarcinomas relies primarily on clinical history, but a 
panel of immunohistochemical markers may be helpful for specific 
tumours. 
Cytological finding Cholangiocarcinoma: 
o Glandular cells in flat, angulated sheets:  
• Low-grade malignant nuclei with nuclear crowding, overlapping, 
slightly irregular nuclear membrane, par chromatin clearing. 
o A range of atypia may be seen from borderline malignant appearing to 
obviously malignant looking. 
o Exaggerated honeycombed pattern from uneven nuclear distribution in 
the sheet. 
o Cell blocks can help by demonstrating sclerotic stroma and cribriforming 
architecture. 
o Mucin stains positive at least focally in many cases. 
o Immunophenotype: keratin 7+,19+;20-;cytoplasmic. 
pCEA, LeuM1, B72.3+ 
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Angiosarcoma:  
Although extremely rare, angiosarcoma is the most common primary 
sarcoma of the liver occurring in older patients with a 3:1 ratio of men to 
women.149 these neoplasms are believed to be secondary to exposure to 
hepatotoxic agents including vinyl chloride, thorotrast, arsenic and 
anabolic steroids. The prognosis is poor. Histologically these neoplasms 
are single or multiple nodules of vascular channels lined by malignant 
endothelial cells. The malignant cells range from being widely spaced 
lining dilated sinusoidal channels to more solid growth filling the 
sinusoids and causing atrophy of the surrounding hepatocytes. An 
epithelioid appearance to the endothelial cells may also occur creating a 
pitfall and misdiagnosis of a carcinoma.69 FNA smears are bloody and 
may be paucicellular.150malignant endothelial cells can be seen 
interdigitating among reactive hepatocytes. They have elongated, 
spindled-shaped hyperchromatic nuclei that are easier to appreciate in 
small dusters than in large clusters where they tend to blend in with the 
hepatocytes. Tumour cells should stain positively for factor 8, CD31, 
CD34, or Ulex europaeus lectin.151'152 
Cytological finding angiosarcoma: 
o Atypical to overtly malignant endothelial cells interspersed with 
hepatocyte clusters 
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o Spindle cell malignancy possibly with blood lakes. 
o Immunocytochemistry stains: Factor VIII, CD31, CD34, ulex 
euroopaeus lectin. 
Embryonal, sarcoma:  
Embryonal sarcoma is a rare malignancy of children typically between 6 
and 10 years of age patients present with abdominal pain or with an 
abdominal mass. Histologically these neoplasms are composed of a 
myxoid stroma embedded with spindled to stellate cells which produces 
FNA smears composed of large, anaplastic cells, multinucleated tumour 
giant cells and atypical spindle cells. Intracytoplasmic globules may be 
seen that are PAS positive but diastase resistant. Tumour cells also stain 
for vimentin, alpha-1 -anti trypsin and alpha-l-antichymotrypsm..153-156. 
Cytological finding: embryonal sarcoma: 
• Hypercellular smears. 
• Large, pleomorphic anaplastic cells with multi nucleated giant cells and 
atypical spindle cells. 
• Intracytoplasmic globules that are PAS positive, diastase resistant. 
• Immunophenotype: vimentin, alpha-1-anti-trypsin and alpha-1-
antichymotrypsin. 
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Malignant neoplasms metastatic: 
The vast majority of malignancies in the liver are metastases,127 and the 
distinction between a primary and metastatic malignancy is of both 
therapeutic and prognostic significance. Past-medical history is of vital 
importance as most patients have a known history of a primary 
malignancy elsewhere. Metastatic tumours tend to recapitulate their 
appearance in the primary organ, and specific tumour types such as small 
cell carcinoma and lymphoma generally maintain a consistent cytological 
appearance. Adenocarcinoma, although frequently recognisable as an 
entity, presents the most difficulty in making a specific diagnosis as to 
site of origin. Adenocarcinoma from the colon is the most common 
metastasis to the liver.157 The presence of an adenocarcinoma with a 'dirty 
necrosis' background is sufficient to diagnose adenocarcinoma consistent 
with colonic primary in a patient with a history of colonic cancer, and 
should direct the clinician to evaluate the colon first in a patient with an 
unknown primary, Other metastatic malignances commonly encountered 
in the liver include those from the pancreas (adenocarcinoma. and 
neuroendocrine tumours), stomach (adenocarcinoma and gastrointestinal 
stromal tumours), breast, lung (adenocarcinoma. small cell carcinoma and 
much less commonly squamous cell carcinoma), skin (melanoma) and 
bladder. Less common but diagnostically more challenging are 
metastases from the kidney and adrenal gland due to the morphological 
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overlap with hepatocellular carcinoma. Sarcomas are the least encoun-
tered tumour type, the most common type being leiomyosarcoma, 
generally from the uterus, and it can be challenging but therapeutically 
important to distinguish metastatic GIST from leiomyosarcoma-158'159 
Lymphoma may also be seen in the liver, most commonly secondary to 
systemic disease, but can be a primary malignancy. If lymphoma is 
suspected on rapid interpretation, request should be made for a dedicated 
FNA for flow cytometry analysis, e.g. one that is not expressed onto a 
slide, rather one in which the aspirated tissue is rinsed into either buffered 
normal saline, cytolyte solution or RPMI. The combination of cytological 
evaluation and flow cytometry immunophenotyping is very often 
sufficient for diagnosis and sub-classification of non-Hodgkin lym-
phoma,160-164 The cytological features helpful in the diagnosis of a variety 
of metastatic tumours are presented below with accompanying supportive 
ancillary tests and illustrations. 
Cytological finding adenocarcinoma (NOS): 
• Polygonal to columnar glandular cells arranged in flat monolayered 
sheets, three-dimensional clusters or singly. 
• Lumens within clusters may be seen in some cases. 
• Nuclei are variably atypical ranging from quite bland in low-grade 
tumours to extremely atypical and obviously malignant in high-grade 
tumours. 
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• Cytoplasm is delicate, frequently vacuolated, and sometimes wispy. 
• Intracytoplasmic mucin may be seen; mucicarmine or other mucin stains 
can help identify focal mucin production. 
Cytological findings; colonic adenocarcinoma:  
• Cigar-shaped, often palisaded nuclei. 
• Variably prominent nucleoli but not macroeosinophilic nucleoli. 
• Dirty necrosis in the background (KEY). 
• Immunocytochemistry: CK20+, CK7-, CEA+, CDX2. 
Cytological findings: breast carcinoma,ductal type: 
• Often low grade with a monomorphous cell population. 
• Flat angulated groups. 
• Single flame or cone-shaped cells. 
• Target cells (cells with intracytoplasmic lumen). 
• Cell-in-cell arrangement. 
Immunocytochemistry; oestrogen/progesterone ± and supportive if 
positive, but non-specific, gross cystic disease protein-15 is supportive if 
positive. 
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Photo 7:  Metastatic colonic carcinoma. (A) This adenocarcinoma is recognised on smears by 
the background of dirty necrosis, a non-specific but characteristic feature. Viable 
aggregates of carcinoma may be few (smear, PAP). (3) CI block shows malignant 
glands composed of tall, crowded columnar ceils adjacent to cellular necrosis 
(HSE). 
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Cytological finding: squamous cell carcinoma: 
• Relatively uncommon metastasis to the liver. 
• Large polygonal cells singly and in clusters. 
• Usually high grade with large, hyper chromatic nuclei with irregular 
nuclear membranes. 
• Cytoplasm is dense and non-vacuolated as opposed to that of 
adenocarcinoma. 
• Keratinising squamous cells stain orangophilic on Papanicolaou stain 
but this feature may not be present. 
Cytological findings squamous cell carcinoma: 
• Small pleomorphic blue cells with little to no cytoplasm in clusters and 
singly. 
• Nuclei are hyperchromatic with coarse, stippled chromatin. 
• Nuclear moulding is common and characteristic. 
• Necrosis and apoptosis is common. 
• Smear or crush artifact is invariably present due to the fragile nature of 
the cells. 
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Cytological findings: well differentiated neuroendocrine carcinoma 
e.g. metastatic pancreatic endocrine neoplasm (PEN) and carcinoid 
tumour:   
• Small uniform blue cells with visible cytoplasm that tends to be scant 
and more evenly pronuclear in carcinoid tumours and more abundant 
and eccentric in PEN. 
• Nuclei with coarse stippled chromatin, more obvious in carcinoids than 
PEN. 
• Nucleoli generally not present in carcinoid tumours but visible in PEN 
• No nuclear molding, much less crush artifact, and no significant 
necrosis/apoptosis compared with small cell undifferentiated carcinoma 
• Immunocytochemistry: Keratin, synaptophysin and chromogranin 
positive. 
Cytological finding large cell lymphoma:  
• Mostly diffuse large B cell lymphoma,-predominantly secondary but 
can be primary. 
• Discohesive, single cell population; may have pseudogroups, e.g. 
artifactual clustering. 
• Lymph glandular bodies (clumps of stripped cytoplasm) in the 
background. 
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• Coarse, frequently peripherally dumped chromatin. 
• Nucleoli may be present. 
• Cytoplasm is scant to invisible, but may be abundant in anaplastic large 
cell lymphoma. 
•  Immunocytochemistry: leukocyte common antigen, CD20,CD19. 
Cytological finding melanoma: 
• Large polygonal cells singly and in clusters; may also be spindled or 
small blue cells with scant cytoplasm. 
• Central to eccentric nuclei with large nucleoli. 
• Intranuclear inclusions common. 
• Cytoplasm is commonly abundant, non-granular and frequently non-
granular and frequency non-pigmented. 
• Immunocytochemistry: S100, HMB-45, Mart-1 and Melan-A positive; 
keratin negative. 
Diagnostic pitfall melanoma: 
Fontana-Masson stain will stain cytoplasmic melanin pigment black but 
will also stain lipofuscin pigment. 
Cytological finding renal cell carcinoma (RCC): 
• Large polygonal cells singly and in clusters. 
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• Transgressing endothelial pattern the most common vascular pattern, 
but peripherally wrapping endothelial pattern is not a feature. 
• Round central nuclei with prominent macro nucleoli ('owl's eye') in 
typical clear/granular cell type; papillary RCC type does not 
demonstrate prominent nucleoli. 
• Intranuclear inclusions can be seen and are frequent in chromophobe 
type. 
• Cytoplasm is commonly abundant and clear or granular; excessive and 
'balloon- like' in chromophobe RCC and scant, often with haemosiderin 
in papillary RCC. 
• Immunocytochemistry: keratin, vimentin and EMA positive; 
• CEA negative.          
Cytological finding adrenal carcinoma:  
• Medium-sized polygonal cells singly and in clusters. 
• No transgressing endothelial pattern but peripherally wrapping 
endothelial pattern may be seen on cell block. 
• Nuclei are variably atypical with hyperchromasia and pleomorphic 
nucleoli which do not tend to be macroeosinophilic as in hepatocellular 
carcinoma. 
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Cytological findings in gastrointestinal stromal tumor (GIST): 
• Prominent vascular pattern. 
• Relatively bland nuclei without overt hyperchromasia or pleomorphism. 
• Delicate cytoplasmic processes. 
• Little to no crush artifact. 
• Immunophenotype: c-kit and CD34 positive; smooth muscle actin 
variably positive; desmin negative. 
Cytological findings: leiomyosarcoma:  
• Pleomorphic spindle cells in tightly cohesive three-dimensional groups 
and syncytia; occasional epithelioid features. 
• No prominent vascular pattern. 
• Hyperch romatic, pleomorphic nuclei with blunted nuclear ends. 
• Cytoplasm is more abundant than GIST. 
• Immunophenotype: desmin and smooth muscle actin positive; c-kit 
negative. 
Role of liver FNA in the management of liver lesions: 
Accurate diagnosis of focal mass lesions in the liver is essential for 
proper patient management. Assuming that a nodule in the liver in a 
patient with a known extra hepatic malignancy represents metastatic 
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disease can- lead to patient mismanagement and over-treatment. Even 
with classic clinical and radiological evidence of metastatic disease from 
a known primary malignancy, confirmation with tissue diagnosis is 
essential for patient enrollment in research protocols and for patients to 
qualify as candidates for new therapies such as ethanol ablation47 and 
targeted gene therapy.48'49 Infections and lymphomas are treated non-
surgically and prompt diagnosis with FNA can expedite appropriate 
patient triage and treatment. 
FNA is the diagnostic procedure of choice for focal liver lesions. When 
performed by experienced interventional radiologists and interpreted by 
experienced pathologists, the accuracy rivals that of frozen section. In 
institutions with considerable experience, the sensitivity of liver FNAB is 
as high as 90% with -specificity approaching l00%.1,11-13 Sampling 
error is the reason for most false negative results that are- most often due 
inexact needle localisation. As such, concomitant core biopsy improves 
accuracy, specificity and sensitivity, and both are better than either 
alone.15’16’30’ 167-169 The distinction between a primary and 
metastatic malignancy is also important for proper patient care. Access to 
the patient's past medical history is of vital importance as most patients 
have a known history of a primary malignancy elsewhere. Metastatic 
colon cancer should be high in the differential diagnosis with or without a 
known primary colon cancer as it is the most common malignancy in the 
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liver. Recognition of the typical smear pattern of an adenocarcinoma with 
palisading columnar cells in a background of dirty necrosis is usually 
sufficient to support the diagnosis in patients with a known history or to 
suggest clinical evaluation of the colon in patients without a known 
history. Familiarity of the typical appearance of extra-hepatic 
malignancies is of benefit as most metastases recapitulate their 
appearance in the primary organ, and specific tumour types such as small 
cell carcinoma and lymphoma generally maintain a consistent cytological 
appearance. 
A focal mass lesion in a cirrhotic liver places HCC at the top of the 
differential diagnosis and prepares the pathologist for the systematic 
smear evaluation. If not already a routine practice, procurement of tissue 
for cell block should be requested of the radiologist in anticipation of 
ancillary studies. 
1.2.2. Imaging of the liver: 
A. ultrasound: 
It is now established as the primary imaging Investigation in 
hepatobiliary disease particularly in the jaundiced patient. It is useful for 
determining bile duct dilatation, the presence of gallstones and presence 
of liver tumors. Also it helps to verify cystic or solid lesions.170 
Beyond doubt that ultrasound can also be used to guide the placement 
of the needle in aspiration cytology or liver biopsy.  
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Photo 8: Ultrasound scan of focal liver lesions
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B. Computerized Tomography scan (C.T scan): 
The triple phase spiral C.T provides fine details of liver lesions 
down to less than 1cm in diameter. Oral contrast enhancement allows 
visualization of the stomach and duodenum in relation to liver hilum, 
with intravenous contrast. The early arterial phase shows small tumors 
owing to their preferential arterial blood supply and the venous phase 
maps the branches of portal vein within the liver and the drainage via 
hepatic veins. 
 
Photo 9: CT-Scan of Focal liver lesions. 
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C. Magnetic Resonance Imaging (MRI): 
MRI though effective as C.T scan, but has the advantage in those 
patients where contrast C.T may not be used due to history of allergy to 
iodine may be offered MRI. Magnetic Resonance Chollangio 
Pancreatography (MRCP) can give excellent imaging of the biliary tree 
non – invasively. Magnetic resonance angiography (MRA) similarly 
provides high quality images of the hepatic artery and portal vein. 
D. Percutaneous Trans Hepatic Cholangiopancreatography  
 (P T C) indicated where ERCP has failed or is impossible as in 
patient with polya type gastrectomy or patient with hilar bile duct 
tumor.170 
E. Angiography 
Angiography may provide useful information on the blood supply 
and architecture of the liver. This also may provide information about the 
nature of a liver nodule and has therapeutic implications as occlusion of 
arterio-venous malformation and embolization of liver tumor.    
F. Laparoscopy and laparoscopic ultrasound: 
This allows direct visualization of the liver and may detect other 
lesions not detected by C.T or MRI. 170 
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1.3. OBJECTIVES 
 
o To correlate between radiological and cytological pattern of focal   
liver lesion. 
o To evaluate focal liver lesion presentation with regard to age group 
gender, clinical presentation and geographical distribution of 
patients.   
o To determine the role of cytological diagnosis in verifying focal 
lesion of the liver. 
o To determine and evaluate the role of diagnostic radiological 
technique in diagnosis of focal liver lesion. 
o To evaluate role of ultrasound guided FNAC versus computed 
tomographic guided FNCA as means of guidance procedure. 
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Chapter 2 
MATERIALS AND METHODS 
2-1 study design: 
This is a retrospective study to evaluate the role of fine needle 
aspiration cytology (FNAC) in diagnosis of focal liver lesions.   FNAC as 
a diagnostic tool is radiodogically guided either by ultrasound or CT-
scan.  The study was conducted at the Police Hospital and Khartoum 
Clinic [A joint committee between (Dr. Ahmed Omer pathologist and Dr. 
Najwa Dongla radiologist)], and the record of patients was from March 
2007 to July 2009 at Khartoum state. 
2-2: study population: 
Sixty one Sudanese’s patients entered this study and were eligible 
for analysis.  Patients were classified according to sex, age, type of 
radiological investigations for diagnosis and type of radiological tools 
used to guide FNAC.  
The result of fine needle aspiration cytology were stated; labeled as 
benign or malignant. All mentioned were variable for analysis.  
All these (61) patient have liver lesions detected by ultrasound or 
C.T scan. The aspirations were made in order to either confirm or rule out 
suspicion of primary or metastatic malignancy in the liver, based on 
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clinical finding, and supported by the presence of unifocal or multifocal 
liver lesions on ultrasound or C-T scan. 
Informed consent was obtained from each patient when viewed for 
the initial aspiration. 
2-3: Sample collections: 
For these sixty one patients many sections taken from every patients 
with focal liver lesion for cytology, collected from patient using the 
ultrasound or C-T guided technique,  so the entry is to the target lesion. 
 
Photo 10: Equipment used for FNAC. 
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Photo 11: Procedure of FNAC 
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Photo 12:  Pressing after procedure  
Technique: 
Specimens for cytologic examination were obtained by direct 
insertion of a long (0.8 mm, 80 mm) 22- gage needle guided by 
ultrasound,  an attendant cytopathologist, and  radiologist are present. The 
penetrating sites of the liver were subcostal.  
After collection the attendant cytopathologist and operator at the 
same time verify the adequate number of cells of the expected type were 
present in the sample.  In cases of unifocal lesions or multifocal one, 
demonstrated by imaging methods (with or without enlarged liver) the 
puncture sites and directions of the needle were directed towards the 
estimated site of the lesion.  
74 
 
 
 
 
 
Photo 13:  Spreading and preparation of slides  
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Photo 14:  Prepared slides 
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Photo 15: Material for cell block   
 
2.4: Sample processing:  For cytology. 
Procedure: 
? Connection of the Gun with 10 ml syringe. 
? Applying negative pressure while lifting & inserting the needle 3-4 
times within the mass.  
? Pulling-out of the Needle. 
? Aspirated tissues are placed on slides. 
? Smear preparation. 
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Fixation: 
- Air-dried smears. 
- Wet-alcohol fixed smears. 
? Cell Block preparation. 
Exclusion: None is excluded, and criteria for exclusions were the 
following: 
1. A history of marked haemorrhagic tendency.  
2. Problems with clotting profiles as: 
o Prolongation of either P-T (prothrombin time) or partial 
thromboplastin time (PTT). 
3. Reduced platelets count. 
The precautions were: 
- Taking a full history, history of marked haemorrhagic tendency. 
- Investigations that include:  
- Complete Blood Count (CBC) platelet count.  
- P.T. 
-P.T.T.  
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2-5: Assessment of the results: 
Sections were examined first by investigator then by two 
cytopatholgist, and they agree about the results, true positive for those 
with malignant focal liver lesions, true negative for those with benign 
disease (including abscess, TB, cyst etc.). Correlations of the results of 
radiography were labeled as unifocal or multifocal and further cytological 
analysis for verification of this result of radiography was done.     
2-6: Ethical considerations: 
The aims of methods and the results and how to get use of results 
were fully explained to the patient before embarking in aspiration and 
their consent is obtained. 
2-7: Cytopathological interpretations: 
Interoperation was done by reviewing of investigator finding by the 
two cytopathologist. Cytological findings were reported as no malignant 
cells seen, definitive malignancies were specified whenever possible.  
The clinical radiological and cytological data were compiled in each 
patient; in one case liver biopsy and immune stain were recommended to 
reach a final diagnosis. 
  In some cases cytologic findings are of use: malignant cells from 
other organs or from body fluids exhibiting malignant cells similar to 
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those obtained by FNAC of the liver Beyond doubt histological 
correlation cell block is ready to be prepared. 
2-8. Statistical analysis: 
To determine the sensitivity and specificity of cytological diagnosis, 
it is necessary to classify cytologic finding for each patient as either 
benign or malignant.   For this purpose patient with cytologic finding of 
no malignant or, genuine benign, and a typical reactions were classified 
as having benign cytological diagnosis, other with definite malignancy or 
suspicious were diagnosed as having malignancy. The cytological finding 
of FNA were categorized as true positive, true negative, false positive and 
false negative. 
A cytological diagnosis was defined as true positive if a patient was 
with malignant cytologic diagnosis had cytologic diagnosis based on 
finding of malignant cell from other organ or body fluids exhibiting 
malignant cells similar to those obtained by FNAC of the liver and 
approved  by radiography and cytology so do negative results. 
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Chapter 3 
RESULTS 
Table 1: describe gender of patients with focal liver lesion in this table 
the frequency for males 46(75.4 %) and for female 15 (26.4 %) in our 
study group hepatic focal lesions are more common in male patient. 
Table 2: Age distribution in details for patient with focal liver lesion 
were between (51- 60) 22 patients 36.1 % followed in descending order 
by age (61 – 70) 10 patients 16.4% then (41 -50) 9 patients (14.8 %). In 
the group studied focal liver lesion are more common in middle age (40-
60) and elderly subject.  
Table 3: this table is for  age of male with focal liver lesion (51-60) 
constitute 30.4%  followed by (61-70) which represent 19.6%, so focal 
liver lesion are common in middle  age  and elderly.  
Table 4: Concerning female patient with focal liver lesion the highest    
percentage   was also as (51-60) 53%.  
Figure 1:  Describes residence of patient with focal liver lesion patient, 
were 32(52.5 %) for those from Khartoum and 29 (47.5%). 
for those from outside Khartoum were 13 from central Sudan, 5 from 
northern 5 from western,6 eastern Sudan  and none from southern Sudan, 
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and their percentage were, 45%, 17 % ,17 % , 21% and 0% , respectively 
As far as those coming out side Khartoum is concerned.  In the study 
group there is an increase in incidence in those coming from central 
Sudan.  
Figure 2: Describes radiography used to diagnose focal liver lesion. C.T 
scan and ultrasound are used.  C.T is the much used radiography for 
detection of focal liver lesions (superior to ultrasonography) 40 patient 
(65%) C.T. 21 patients (35%) U/S was the diagnostic radiography to offer 
diagnosis of focal liver lesion.  
Figure 3 : showing  result of radiography, that were unifocal lesion 
which constitute 57% and 43%  for  multifocal lesion.    
Table 5: Show clinical presentation of patients with focal   liver lesion 
the most common presentation is with hepatic mass which can be single 
or multiple. 
Table 6 shows radiographic technique used to guide FNAC 57 patients 
93.4 % underwent U/S guided aspiration, and four 4 patients 6.6% 
underwent CT guided aspiration.  It is evident that ultrasound as a means 
of guidance of FNAC is superior to CT guidance.  
Table 7: shows results of cytology benign aspiration 17(28%) for 
malignancy aspiration 44(72%). 
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Figure 5: showing verification of unifocal lesion. (60%) malignant (37%)   
benign and (3%) suspicious.  
Figure 6: showing verification of malignancy in unifocal lesion by FNA. 
(71%) secondary malignancy (29%) primary malignancy 
Figure 7:  showing verification of benign unifocal lesion by FNA (38.%) 
Liver abscess (23%) haemoagioma, (15%) cyst, (8%) bile duct 
hyperplasia (8%) chronic inflammatory (8%) benign with scattered 
atypical cells. 
Figure 8: showing result of cytology of multifocal lesion by FNA (85%) 
malignant (15%)   benign.  
Figure 9: showing verification of malignancy in multifocal lesion by 
FNA. (77%) secondary malignancy (18%) primary (5%) malignant. 
Figure 10: showing verification of benign multifocal lesion by FNA 
(25%) nodular hyperplasia (25%) haemoagioma, (25%) cyst, (25%) TB. 
This was proved by PCR.     
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Table 1   Gender distribution of patients with focal liver lesion 
Sex Frequency Percent 
Male 46  75.4 
Female 15 24.6 
Total  61  100.0 
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Table 2: Age group for patient with focal liver lesion Number: 61  
 
Percent  Frequency Age (in years) 
3.3 2    0-10   
4.9 3 11-20 
3.3 2 21-30 
9.8 6 31-40 
14.8 9 41-50 
36.1 22 51-60 
16.4 10 61-70 
8.2 5 71-80 
3.3 2 81-90 
100.0 61 Total 
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Table 3: Age group for male patients with a focal liver lesion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percent Frequency     Age (in years) 
4.3 2 0-10 
4.3 2 11-20 
4.3 2 21-30 
8.7 4 31-40 
15.2 7 41-50 
30.4 14 51-60 
19.6 9 61-70 
8.7 4 71-80 
100.0 46 Total 
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Table 4: Age group for female patients with a focal liver lesion.  
 
Age (in years) Frequency Percent 
0‐10  0 0 
11‐‐20  1 7 
31‐40  2 13 
41‐50  2 13 
51‐60  8 53 
61‐70  1 7 
71‐80  1 7 
Total   15 100 
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Table 5: Clinical presentations of patients with focal liver lesion. 
Clinical presentations Frequency Percentage 
Hepatic mass 32 52 
hepatomegaly + Lymphadenopthies 2 3 
Abdominal. mass and hepatomegaly 18 30 
 Abdominal  pain  and hepatomegaly 2 3 
Abdominal distention  and hepatomegaly 1 2 
Rt. sub costal subcutaneous mass   1 2 
Others (renal mass, ascites, pleural effusion, 
nipple discharge  and peritoneal nodule 
5 8 
Total 61 100 
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Table 6: Show residence of patients from outside Khartoum. 
 Residence Percent Frequency 
Central Sudan 13 45 
Western Sudan 5 17 
Eastern Sudan 6 21 
Northern Sudan 5 17 
Total 29 100 
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Table 7: FNAC guided radiographic technique 
FNAC guided Percent Frequency 
U/S guided 57 93.4 
C.T scan guided 4 6.6 
Total 61  100.0 
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Table 8: Cytology result of patients with focal liver lesions 
 
Cytological result Percent Frequency 
Benign aspiration  17 28 
Malignancy  44 72 
Total 61 100.0 
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Figure 1: 
 
Residence of patients with focal liver lesions 
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Figure 2:  
 
Radiograph for technique used for diagnosis of focal liver lesions 
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Figure 3: 
 
Results of radiographic technique used for diagnosis of focal 
liver lesions 
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Figure 4:  
 
Verifying of unifocal liver lesions by cytology  
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Figure 5: 
 
Verification of malignancy in unifocal liver lesions by FNA. 
 
 
 
 
96 
 
 
 
Figure 6: 
 
Verification of benign unifocal lesions by FNA. 
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Figure 7: 
 
Results of cytology of multifocal lesions by FNA 
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Figure 8: 
 
Verification of malignant multifocal liver lesions by FNA 
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Figure 9: 
 
Verification of benign multifocal liver lesions by FNA 
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Chapter 4 
DISCUSSION 
FNAC is a procedure available for more than two decades. It is a 
very useful procedure for the diagnosis of various hepatic lesions. It 
offers accuracy without major complication and minimal interventions at 
low cost. The only absolute contraindications are marked haemorrhagic 
diathesis and suspected vascular lesion.(171) No complications during this 
study were found. It is of interest to realize that FNAC of the liver guided 
by ultrasound or C.T. scan has proved to be a safe and an accurate 
method for diagnosis of focal hepatic lesions. 
The main aim of the study is to evaluate the diagnosis of focal liver 
lesion by FNA guided by radiography. 
In this study patients presented with different clinical features, some 
with right hypochondrial pain or tenderness other with abdominal pain. 
Weight loss is a common feature for patients. Examination in most 
patients revealed spectrum of hepatomegaly, nodular liver, hepatic mass, 
abdominal mass and some patients with ascites. The most important 
requirement for such cytodiagnosis is a representative sample from the 
lesion, and in our case the lesion is located by the guided radiography C.T 
or U/S, and the operator is expert, so no problem with a representative 
sample. Patients were subjected to ultrasonography guided FNA which 
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has been reported to be safe useful and accurate technique for making 
cytological diagnosis of hepatic masses.(172-173) Accordingly to imaging 
scanning hepatic lesions were grouped as unifocal and multifocal, which 
represent 57% and 43% respectively. Images guidance of FNA yield 
representative sampling of lesions. Special Imaging scanning suggesting 
multifocal lesions. It is of interest to realize that, no detection of 
pathologic findings by imaging liver scans does not preclude the presence 
of malignancy.  
In our study most of the patient came from Khartoum state 32 
patients and 29 patients from outside Khartoum state distributed as 13 
from central Sudan (area extending from Gezira, white Nile, and blue 
Nile).6 from eastern Sudan,  5 patients reside northern Sudan, 5 patients 
from western Sudan.  
The patients age range from 1-82 year with male predominance. It 
was noticed that focal liver lesions are common in middle age group 40-
60 years in both sexes, the incidence for male patient is more as 
compared with female, younger age group are not exempted from focal 
liver lesion. One case is diagnosed as hepatoblastoma, after examination 
of its cell block. This case came from Alnohood Western Kordofan, the 
same area for hepatocellular carcinoma. 
The present study was conducted in order to establish the role of fine 
needle aspiration cytology as a reliable diagnostic method. The cytologic 
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diagnosis of malignancy was confirmed in 44 patients (72.0%), by 
matching the result of radiography and the feature suggestive of 
malignancy.       
In addition, to this there is supported evidence in some patients 
examples matching with cytologic tumor cells obtained from other organs 
for instance a malignant renal and liver aspirate. 
Morphologically, malignant lesions constituted 72% and benign 
lesions 28% for both uni and multifocal liver lesions. For unifocal lesions 
malignancy was found in 60% and benign lesions in 37% and 3% of 
cases were suspicious. For multifocal liver lesions 85% were malignant 
and 15% were benign. Secondary malignancies were more common than 
primary malignancy, constituting 71% and 77% for unifocal, multifocal 
liver lesions respectively.    
Primary malignant liver tumours were 29% of uni focal and 18% of 
multifocal lesions. In one patient there was a need for liver biopsy and 
immunostain to arrive at a final diagnosis of malignancy.   
In order to lower the rate of false negative cytologic findings, we 
suggest that FNA should be repeated in patient clinically suspected of 
having malignancy despite negative cytologic findings. Fortunately this 
pitfall is not found in our studied group. Negative cytologic findings 
17(28.0%) were viewed with caution in order to rule out false negative 
rate that were zero in our study. In the group studied no complication of 
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the procedure is noted except pain, tenderness at the puncture site that 
was not infrequent.  
Under the umbrella of focal liver lesion whether unifocal or 
multifocal many entities exist including benign and malignant condition     
This study highlighted the role played by radiologist, pathologist and 
clinician in verifying focal liver lesions.   
Clinician in term of providing a full history with regard to the 
patient history and a full clinical examination from head to heal. A 
competent radiologist understanding patient clinical history and 
examination and mastering his job diagnosed competently focal hepatic 
lesion and gave advice regarding its verification. Also the radiologist help 
in obtaining FNAC by the C.T or U/S. The collaboration between 
clinician, radiologist, and pathologist opinion cut the way to diagnosis.  
Feedback between the three help in improving the health services in our 
beloved country, Sudan. 
It is of interest to reflect the role of cell block   although not included 
in all cases in our study it is among the oldest method for preparing 
material for microscopic examination. The method uses histologic 
technique for processing and thus offer one major advantages, multiple 
sections of the same material may be processed for special stains that may 
serve for identification of mucin, melanin or other cell product. The cell 
block technique should be used for processing all residential material 
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remaining after completion of cytologic preparation.  This material often 
contains valuables diagnostic evidence and tissue fragment that cannot be 
processed by cytology, also this provide ability to perform multiple 
immunohistochemistry or other special stains if needed. So cell block 
should be employed to help verifying cytology.  
It is a fact that immunohistochemistry has rapidly become an 
integral part of most diagnostic tool, which confirms histological results. 
This technique helps to differentiate primary hepatocellular carcinoma 
and metastatic carcinoma. Positive alpha fetoprotein, strongly support the 
diagnosis of primary hepatocellular carcinoma. For metastatic carcinoma 
following help with S100, vimentin, cytokeratin and epithelial membrane 
antigens.  
The result of this retrospective study FNAC guided by U/S or C.T 
scan is easy and accurate for use, this is not meant to replace U/S guided 
needle biopsy in major centers outside Sudan. This procedure could be 
cut-short by early finding of abnormal cells. It allows rapid microscopic 
diagnosis. 
FNAC guided radiography (U/S or C.T scan) is less expensive, with 
high clinical benefit for both diagnosis and therapy, and this will be the 
goal for clinicians, health care policy makers and patients.  
In the present setup from this study it is felt that USG guided FNAC 
is very useful in diagnosis of different hepatic lesions as the procedure is 
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simple and safe.  The results are obtained quickly without serious 
complications related to the procedure. So FNAC is a simple and 
effective diagnostic tool in our hand.  
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CONCLUSION AND RECOMMENDATION 
- Ultrasound or C.T guided fine needle aspiration cytology (F.N.A.C) is a 
useful clues test for diagnosis and evaluation of patient with focal liver 
lesion (unifocal or multifocal). 
- With presence of an expert radiologist and cytopathologist it cut the way 
to making a correct diagnosis of focal liver lesions. The role of 
correlation between discipline of medicine in diagnosis and management 
of patients with focal liver lesion should be established to advocate the 
multidisciplinary approach in handling of patients. 
- Not only malignancy can be proved by such a procedure, A number of 
other conditions as pyogenic liver abscess, tuberculosis and liver 
hemangioma …etc.  
- Radiographic guided FNAC can differentiate benign focal liver lesions 
against malignancy and also in many cases can verify secondary deposits 
with help of others features for example finding same cytological pattern 
in other masses. 
Ultrasound guided FNAC is useful diagnostic test for evaluation of 
patients with discrete hepatic mass and superior to CT guided FNAC 
except for   very small lesion.  
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-Beyond doubt immunocychimestry is a major tool in the differentiation 
between primary and secondary liver cancer and its implication is advised 
to verify secondary. 
-It is concluded that fine needle aspiration cytology under image guidance 
has increasing acceptance as a means of evaluation of focal liver lesions, 
and in evaluating liver mass, however there are some difficulties which 
can be over come by more experience in aspiration, and better co-
ordination between radiologists, pathologists and clinicians. 
Further study in this aspect is recommended with a large number of 
patients with focal liver lesion with stress on cell block and 
immunehistochemistry techniques.  
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Appendix 
QUESTIONNAIRE 
Evaluation of the role of FNAC in diagnosis of focal liver lesion  
Date:  …………………………………   Block no : ……………….. 
Patient name :…………………………… 
1. Residence                                       (Khartoum / outside Khartoum)  
2. Age  
3. History of liver disease                   Yes                   No  
4. History of previous operation          Yes                   No  
5. Symptoms of patient:                      Yes                   No  
   - Weight loss                                    
   - Abdominal pain                              
6. Sign of patients                             Yes                        No  
  -Palpable liver mass  
  - Ascites  
  - Abdominal mass 
-Others  
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7. Radiological fool to diagnose liver lesion     Yes                   No  
a. U/S          Yes                        No  
b.  C/T         Yes                        No  
8. Result of radiography image        Yes                          No  
a. multiple liver lesion  (Unifocal)     Yes                        No  
b. single liver lesion   (Multifocal)     Yes                         No  
9. cytological result    
Primary malignancy                       Yes                         No  
Secondary malignancy                   Yes                        No  
Benign aspirate                              Yes                       No  
10. Verification of unifocal lesion  
-Benign              Yes                   No 
- Malignant         Yes                   No  
11. Verification of multifocal lesion            Yes                   No  
-Benign            Yes                   No 
- Malignant       Yes                   No 
    
 
 
